| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sulfur compound binding | PRMT8 NCAM1 ITGA2 NELL2 PTPRF PTPRS LRRTM4 MPO APOH EVA1C THBS3 METTL5 FSTL1 PCIF1 LGR6 | 2.47e-05 | 323 | 261 | 15 | GO:1901681 |
| GeneOntologyMolecularFunction | phosphoprotein binding | 1.53e-04 | 117 | 261 | 8 | GO:0051219 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor | 1.70e-04 | 2 | 261 | 2 | GO:0016639 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase [NAD(P)+] activity | 1.70e-04 | 2 | 261 | 2 | GO:0004353 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NAD+) activity | 1.70e-04 | 2 | 261 | 2 | GO:0004352 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NADP+) activity | 1.70e-04 | 2 | 261 | 2 | GO:0004354 | |
| GeneOntologyMolecularFunction | heparin binding | 2.26e-04 | 192 | 261 | 10 | GO:0008201 | |
| GeneOntologyMolecularFunction | benzoate-CoA ligase activity | 5.06e-04 | 3 | 261 | 2 | GO:0018858 | |
| GeneOntologyMolecularFunction | integrin binding | 5.08e-04 | 175 | 261 | 9 | GO:0005178 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 5.28e-04 | 51 | 261 | 5 | GO:0043394 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 6.80e-04 | 31 | 261 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ERCC2 ATAD5 ATP8A1 KIF2B ABCG2 DDX60L NSF DHX40 ATP10D RAD50 MTREX ATP12A ATP2A1 HSPA14 AFG1L | 7.38e-04 | 441 | 261 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 8.52e-04 | 151 | 261 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | phospholipid binding | PSAP PSG6 MBL2 GAS6 OBSCN FAAH ITPR3 SNX6 SNX10 SNX31 ANXA9 TRPV1 OGT ATG2B APOH ZFYVE26 CPNE7 | 9.30e-04 | 548 | 261 | 17 | GO:0005543 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | SRC OBSCN ITGA2 ITGAE ITGAV ITGB2 JAM2 PTPN6 PTPRD PTPRF ROBO3 CNTN4 ANK3 TNC GSK3B CDH4 PALLD FRMD5 | 9.52e-04 | 599 | 261 | 18 | GO:0050839 |
| GeneOntologyMolecularFunction | hyaluronan synthase activity | 1.00e-03 | 4 | 261 | 2 | GO:0050501 | |
| GeneOntologyMolecularFunction | decanoate-CoA ligase activity | 1.00e-03 | 4 | 261 | 2 | GO:0102391 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | NEXMIF SRC CLASP2 ITGA2 ITGAE ITGAV ITGB2 RIN2 PKHD1 FGL1 TECTA GSK3B THBS3 SIGLEC1 | 1.24e-05 | 270 | 267 | 14 | GO:0007160 |
| GeneOntologyBiologicalProcess | cell morphogenesis | MYCBP2 SRC NCAM1 CLASP2 ITGB2 ADCY1 BRWD3 NEDD4 STRADB NELL2 PTPN6 KANK1 HMCN2 PTPRD PTPRF PLPPR4 FGD4 PTPRS PKHD1 ROBO3 CNTN4 HSPG2 ANK3 LMTK2 SPG11 TECTA THOC5 GSK3B LIFR RABL2B RABL2A LGR6 CDH4 PALLD | 1.34e-05 | 1194 | 267 | 34 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuromuscular junction development | 2.78e-05 | 68 | 267 | 7 | GO:0007528 | |
| GeneOntologyBiologicalProcess | response to metal ion | MYLK ZNF658 TRPM2 NCAM1 ADCY1 ADCY8 CHUK NEDD4 ITPR3 GCLC GLUD1 GLUD2 EIF2AK3 ANK3 GSK3B ATP12A CPNE7 | 3.17e-05 | 415 | 267 | 17 | GO:0010038 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MYCBP2 NCAM1 CLASP2 ADCY1 NEDD4 NELL2 HMCN2 PTPRD PTPRF PLPPR4 PTPRS ROBO3 CNTN4 HSPG2 ANK3 LMTK2 SPG11 TECTA GSK3B RABL2B RABL2A LGR6 CDH4 PALLD | 4.38e-05 | 748 | 267 | 24 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PSG6 ITGB2 HMCN2 PTPRD PTPRF PTPRS ROBO3 MPZ CNTN4 FAT4 PCDHGA11 HMCN1 CDH4 PALLD | 6.26e-05 | 313 | 267 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell junction organization | PRMT8 LRRC24 MYCBP2 PSG6 SRC CLASP2 ITGA2 ITGAV NEDD4 HMCN2 PTPRD PTPRF PLPPR4 PTPRS LRRTM4 PKHD1 MPZ CNTN4 CACNB4 OGT ANK3 TNC NBEA SPG11 GSK3B SETD5 CDH4 PALLD | 6.95e-05 | 974 | 267 | 28 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | NEXMIF SRC GAS6 CLASP2 ITGA2 ITGAE ITGAV ITGB2 KANK1 RIN2 PKHD1 FGL1 TECTA GSK3B THBS3 SIGLEC1 | 9.56e-05 | 410 | 267 | 16 | GO:0031589 |
| GeneOntologyBiologicalProcess | axon development | MYCBP2 NCAM1 CLASP2 ADCY1 NELL2 HMCN2 PTPRF PLPPR4 PTPRS ROBO3 CNTN4 HSPG2 ANK3 TNC LMTK2 SPG11 GSK3B MTR LGR6 CDH4 PALLD | 1.02e-04 | 642 | 267 | 21 | GO:0061564 |
| GeneOntologyBiologicalProcess | symbiont entry into host | SPINT1 SRC GAS6 NCAM1 ITGA2 ITGAV IFITM1 IFITM2 RAD50 SIGLEC1 | 1.03e-04 | 176 | 267 | 10 | GO:0044409 |
| GeneOntologyBiologicalProcess | acute-phase response | 1.13e-04 | 59 | 267 | 6 | GO:0006953 | |
| GeneOntologyCellularComponent | side of membrane | PRMT8 LRRC24 PDGFRA PSG6 MBL2 PRND NCAM1 ITGA2 ITGAE ITGAV ITGB2 CHUK ITPR3 PTPN3 PLPPR4 PKHD1 ABCG2 ADGRA3 CNTN4 CACNB4 TRPV1 ANK1 NOA1 ADAM29 TECTA LIFR BORCS8 CD3G CNTN3 IL5RA | 7.97e-07 | 875 | 265 | 30 | GO:0098552 |
| GeneOntologyCellularComponent | extracellular matrix | A2M SERPINA3 PSAP LRRC24 NCAM1 HMCN2 OTOGL LRRTM4 ADAMTS20 FGL1 ANXA9 HSPG2 MXRA5 TNC APOH TECTA ORM1 ORM2 THBS3 HMCN1 LRIG1 LGR6 | 3.53e-05 | 656 | 265 | 22 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | A2M SERPINA3 PSAP LRRC24 NCAM1 HMCN2 OTOGL LRRTM4 ADAMTS20 FGL1 ANXA9 HSPG2 MXRA5 TNC APOH TECTA ORM1 ORM2 THBS3 HMCN1 LRIG1 LGR6 | 3.69e-05 | 658 | 265 | 22 | GO:0030312 |
| GeneOntologyCellularComponent | external side of plasma membrane | LRRC24 PDGFRA PSG6 MBL2 PRND NCAM1 ITGA2 ITGAE ITGAV ITGB2 PLPPR4 PKHD1 ABCG2 ADGRA3 TRPV1 ADAM29 LIFR CD3G IL5RA | 3.82e-05 | 519 | 265 | 19 | GO:0009897 |
| GeneOntologyCellularComponent | I band | 5.31e-05 | 166 | 265 | 10 | GO:0031674 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.01e-04 | 59 | 265 | 6 | GO:0098636 | |
| GeneOntologyCellularComponent | Z disc | 1.36e-04 | 151 | 265 | 9 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcomere | OBSCN DES FBXO32 MYO18B ANK1 ANK3 CSRP3 UNC45B ATP2A1 PALLD MYBPC2 | 3.55e-04 | 249 | 265 | 11 | GO:0030017 |
| GeneOntologyCellularComponent | A band | 5.04e-04 | 52 | 265 | 5 | GO:0031672 | |
| GeneOntologyCellularComponent | integrin complex | 6.87e-04 | 32 | 265 | 4 | GO:0008305 | |
| GeneOntologyCellularComponent | myofibril | OBSCN DES FBXO32 MYO18B ANK1 ANK3 CSRP3 UNC45B ATP2A1 PALLD MYBPC2 | 7.65e-04 | 273 | 265 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 8.31e-04 | 155 | 265 | 8 | GO:0098685 | |
| GeneOntologyCellularComponent | axon | MYO1A PDGFRA MYCBP2 SRC NCAM1 CLASP2 ITGA2 ADCY8 NCDN JAM2 HMCN2 PTPRF PTPRS SYP ROBO3 CNTN4 ANK1 ANK3 LMTK2 SPG11 GSK3B SLC4A10 PALLD | 1.03e-03 | 891 | 265 | 23 | GO:0030424 |
| GeneOntologyCellularComponent | spindle | KNTC1 ERCC2 DCDC1 CLASP2 BIRC6 CEP350 KIF2B ASPM PKHD1 GPSM2 SGF29 ANAPC5 WDR62 GSK3B BORA | 1.06e-03 | 471 | 265 | 15 | GO:0005819 |
| GeneOntologyCellularComponent | contractile muscle fiber | OBSCN DES FBXO32 MYO18B ANK1 ANK3 CSRP3 UNC45B ATP2A1 PALLD MYBPC2 | 1.25e-03 | 290 | 265 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | A2M SERPINA3 PSAP NCAM1 HMCN2 ADAMTS20 FGL1 ANXA9 HSPG2 MXRA5 TNC APOH ORM1 ORM2 THBS3 HMCN1 | 1.27e-03 | 530 | 265 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | anchoring junction | MYLK PSG6 SRC OBSCN NCAM1 CLASP2 ITGA2 ITGAV ITGB2 JAM2 DES PTPN6 AKAP6 HSPG2 ANK3 TNC UBOX5 RND3 IGF2R HMCN1 STX16 CDH4 PALLD FRMD5 | 1.55e-03 | 976 | 265 | 24 | GO:0070161 |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 1.60e-03 | 67 | 265 | 5 | GO:0031093 | |
| GeneOntologyCellularComponent | meiotic spindle | 1.68e-03 | 19 | 265 | 3 | GO:0072687 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | TRAV9-2 PSG6 ITGA2 ITGAE ITGAV ITGB2 CHUK PTPN6 LRRTM4 CD3G TRAV30 TRAV13-1 | 1.79e-03 | 350 | 265 | 12 | GO:0098802 |
| GeneOntologyCellularComponent | somatodendritic compartment | TRPM4 BRINP3 MYO1A TRPM2 SRC NCAM1 ADCY8 NCDN NEDD4 ITPR3 JAM2 NELL2 PTPN6 HMCN2 PTPRF PTPRS BRD1 CACNA1E TRPV1 OGT ANK3 NSF LMTK2 SPG11 GSK3B PHAF1 SLC4A10 PALLD | 1.95e-03 | 1228 | 265 | 28 | GO:0036477 |
| GeneOntologyCellularComponent | cell surface | LRRC24 PDGFRA PSG6 MBL2 PRND NCAM1 ITGA2 ITGAE ITGAV ITGB2 JAM2 PLPPR4 PKHD1 ABCG2 ANXA9 ADGRA3 IGSF3 TRPV1 ANK3 IFITM1 ADAM29 APOH LIFR CD3G IGF2R IL5RA | 1.98e-03 | 1111 | 265 | 26 | GO:0009986 |
| MousePheno | decreased brain weight | CSMD3 PLPPR4 ASPM ZDHHC13 WDR62 OGT SPG11 RABL2B RABL2A ZFYVE26 | 7.60e-06 | 106 | 224 | 10 | MP:0002175 |
| MousePheno | abnormal brain weight | CSMD3 PLPPR4 ASPM ZDHHC13 WDR62 OGT NBEA SPG11 RABL2B RABL2A ZFYVE26 | 2.61e-05 | 148 | 224 | 11 | MP:0012775 |
| MousePheno | wide sternum | 3.96e-05 | 5 | 224 | 3 | MP:0012279 | |
| MousePheno | pulmonary hyperplasia | 3.96e-05 | 5 | 224 | 3 | MP:0004202 | |
| MousePheno | abnormal skin physiology | ERCC2 TMPRSS13 ITGB2 CHUK PTPN6 BRCA1 ARIH2 ABCG2 FGL1 HSPG2 TRPV1 MAP3K6 SDR9C7 ZNF750 LRIG1 | 6.37e-05 | 288 | 224 | 15 | MP:0005501 |
| Domain | Ig_I-set | MYLK LRRC24 PDGFRA FSTL5 OBSCN NCAM1 JAM2 HMCN2 PTPRD PTPRF PTPRS ROBO3 ADGRA3 CNTN4 HSPG2 MXRA5 HMCN1 LRIG1 CNTN3 SIGLEC1 PALLD MYBPC2 | 2.74e-14 | 190 | 261 | 22 | IPR013098 |
| Domain | I-set | MYLK LRRC24 PDGFRA FSTL5 OBSCN NCAM1 JAM2 HMCN2 PTPRD PTPRF PTPRS ROBO3 ADGRA3 CNTN4 HSPG2 MXRA5 HMCN1 LRIG1 CNTN3 SIGLEC1 PALLD MYBPC2 | 2.74e-14 | 190 | 261 | 22 | PF07679 |
| Domain | IGc2 | MYLK LRRC24 PDGFRA PSG6 FSTL5 OBSCN NCAM1 JAM2 HMCN2 PTPRD PTPRF PTPRS ROBO3 IGSF3 CNTN4 HSPG2 MXRA5 CD3G HMCN1 LRIG1 CNTN3 SIGLEC1 PALLD MYBPC2 | 3.00e-14 | 235 | 261 | 24 | SM00408 |
| Domain | Ig_sub2 | MYLK LRRC24 PDGFRA PSG6 FSTL5 OBSCN NCAM1 JAM2 HMCN2 PTPRD PTPRF PTPRS ROBO3 IGSF3 CNTN4 HSPG2 MXRA5 CD3G HMCN1 LRIG1 CNTN3 SIGLEC1 PALLD MYBPC2 | 3.00e-14 | 235 | 261 | 24 | IPR003598 |
| Domain | IG | MYLK LRRC24 PDGFRA PSG6 FSTL5 OBSCN NCAM1 JAM2 HMCN2 PTPRD PTPRF PTPRS ROBO3 ADGRA3 IGSF3 MPZ CNTN4 HSPG2 MXRA5 HMCN1 LRIG1 CNTN3 SIGLEC1 PALLD MYBPC2 | 1.28e-09 | 421 | 261 | 25 | SM00409 |
| Domain | Ig_sub | MYLK LRRC24 PDGFRA PSG6 FSTL5 OBSCN NCAM1 JAM2 HMCN2 PTPRD PTPRF PTPRS ROBO3 ADGRA3 IGSF3 MPZ CNTN4 HSPG2 MXRA5 HMCN1 LRIG1 CNTN3 SIGLEC1 PALLD MYBPC2 | 1.28e-09 | 421 | 261 | 25 | IPR003599 |
| Domain | IG_LIKE | MYLK LRRC24 PDGFRA PSG6 FSTL5 OBSCN NCAM1 JAM2 HMCN2 PTPRD PTPRF PTPRS ROBO3 ADGRA3 IGSF3 MPZ CNTN4 HSPG2 MXRA5 CD3G HMCN1 LRIG1 CNTN3 SIGLEC1 PALLD MYBPC2 | 6.50e-09 | 491 | 261 | 26 | PS50835 |
| Domain | Ig-like_dom | MYLK LRRC24 PDGFRA PSG6 FSTL5 OBSCN NCAM1 JAM2 HMCN2 PTPRD PTPRF PTPRS ROBO3 ADGRA3 IGSF3 MPZ CNTN4 HSPG2 MXRA5 CD3G HMCN1 LRIG1 CNTN3 SIGLEC1 PALLD MYBPC2 | 1.07e-08 | 503 | 261 | 26 | IPR007110 |
| Domain | - | MYLK LRRC24 PDGFRA MYCBP2 PSG6 FSTL5 OBSCN NCAM1 JAM2 PTPRD PTPRF PTPRS PKHD1 ROBO3 ADGRA3 IGSF3 MPZ CNTN4 HSPG2 MXRA5 TNC LIFR CD3G HMCN1 LRIG1 CNTN3 SIGLEC1 PALLD IL5RA MYBPC2 | 1.57e-08 | 663 | 261 | 30 | 2.60.40.10 |
| Domain | Ig-like_fold | MYLK LRRC24 PDGFRA MYCBP2 PSG6 FSTL5 OBSCN NCAM1 JAM2 HMCN2 PTPRD PTPRF PTPRS PKHD1 ROBO3 ADGRA3 IGSF3 MPZ CNTN4 HSPG2 MXRA5 TNC LIFR CD3G HMCN1 LRIG1 CNTN3 SIGLEC1 PALLD IL5RA MYBPC2 | 1.77e-08 | 706 | 261 | 31 | IPR013783 |
| Domain | ig | PDGFRA PSG6 FSTL5 OBSCN NCAM1 JAM2 PTPRD PTPRS ADGRA3 CNTN4 HSPG2 HMCN1 CNTN3 SIGLEC1 | 4.82e-07 | 190 | 261 | 14 | PF00047 |
| Domain | Immunoglobulin | PDGFRA PSG6 FSTL5 OBSCN NCAM1 JAM2 PTPRD PTPRS ADGRA3 CNTN4 HSPG2 HMCN1 CNTN3 SIGLEC1 | 4.82e-07 | 190 | 261 | 14 | IPR013151 |
| Domain | fn3 | MYLK OBSCN NCAM1 PTPRD PTPRF PTPRS ROBO3 CNTN4 TNC LIFR CNTN3 MYBPC2 | 3.03e-06 | 162 | 261 | 12 | PF00041 |
| Domain | FN3 | MYLK OBSCN NCAM1 PTPRD PTPRF PTPRS ROBO3 CNTN4 TNC LIFR CNTN3 IL5RA MYBPC2 | 4.73e-06 | 199 | 261 | 13 | PS50853 |
| Domain | FN3_dom | MYLK OBSCN NCAM1 PTPRD PTPRF PTPRS ROBO3 CNTN4 TNC LIFR CNTN3 IL5RA MYBPC2 | 8.07e-06 | 209 | 261 | 13 | IPR003961 |
| Domain | FN3 | MYLK OBSCN NCAM1 PTPRD PTPRF PTPRS ROBO3 CNTN4 TNC LIFR CNTN3 MYBPC2 | 1.18e-05 | 185 | 261 | 12 | SM00060 |
| Domain | PTPc | 1.36e-04 | 36 | 261 | 5 | SM00194 | |
| Domain | ELFV_dehydrog_N | 1.95e-04 | 2 | 261 | 2 | PF02812 | |
| Domain | Glu/Leu/Phe/Val_DH_C | 1.95e-04 | 2 | 261 | 2 | IPR006096 | |
| Domain | Glu/Leu/Phe/Val_DH_dimer_dom | 1.95e-04 | 2 | 261 | 2 | IPR006097 | |
| Domain | Glu/Leu/Phe/Val_DH | 1.95e-04 | 2 | 261 | 2 | IPR006095 | |
| Domain | ELFV_dehydrog | 1.95e-04 | 2 | 261 | 2 | PF00208 | |
| Domain | NAD_bind_Glu_DH | 1.95e-04 | 2 | 261 | 2 | IPR033922 | |
| Domain | GLFV_DEHYDROGENASE | 1.95e-04 | 2 | 261 | 2 | PS00074 | |
| Domain | A1A_glycop | 1.95e-04 | 2 | 261 | 2 | IPR001500 | |
| Domain | ELFV_dehydrog | 1.95e-04 | 2 | 261 | 2 | SM00839 | |
| Domain | Glu/Leu/Phe/Val_DH_AS | 1.95e-04 | 2 | 261 | 2 | IPR033524 | |
| Domain | TYR_PHOSPHATASE_PTP | 2.00e-04 | 39 | 261 | 5 | PS50055 | |
| Domain | PTPase_domain | 2.55e-04 | 41 | 261 | 5 | IPR000242 | |
| Domain | Y_phosphatase | 2.55e-04 | 41 | 261 | 5 | PF00102 | |
| Domain | EGF_CA | 3.19e-04 | 122 | 261 | 8 | SM00179 | |
| Domain | Growth_fac_rcpt_ | 3.54e-04 | 156 | 261 | 9 | IPR009030 | |
| Domain | EGF-like_Ca-bd_dom | 3.56e-04 | 124 | 261 | 8 | IPR001881 | |
| Domain | Integrin_dom | 3.74e-04 | 25 | 261 | 4 | IPR032695 | |
| Domain | EGF_Ca-bd_CS | 4.23e-04 | 97 | 261 | 7 | IPR018097 | |
| Domain | EGF_CA | 4.79e-04 | 99 | 261 | 7 | PS01187 | |
| Domain | Tyr_Pase_AS | 5.47e-04 | 73 | 261 | 6 | IPR016130 | |
| Domain | HAS/NodC | 5.78e-04 | 3 | 261 | 2 | IPR026107 | |
| Domain | - | TRANK1 PEX5 GPSM2 ANAPC5 OGT RPAP3 LRPPRC UNC45B VPS41 IFT122 | 6.88e-04 | 207 | 261 | 10 | 1.25.40.10 |
| Domain | - | 6.96e-04 | 13 | 261 | 3 | 1.10.540.10 | |
| Domain | AcylCoA_DH/ox_N | 6.96e-04 | 13 | 261 | 3 | IPR013786 | |
| Domain | EGF-like_dom | GAS6 NELL2 HMCN2 HSPG2 FAT4 TNC ADAM29 TECTA THBS3 OIT3 HMCN1 | 7.91e-04 | 249 | 261 | 11 | IPR000742 |
| Domain | EGF_1 | GAS6 ITGB2 NELL2 HMCN2 HSPG2 FAT4 TNC ADAM29 THBS3 OIT3 HMCN1 | 9.60e-04 | 255 | 261 | 11 | PS00022 |
| Domain | - | 9.85e-04 | 32 | 261 | 4 | 3.40.1110.10 | |
| Domain | - | 9.85e-04 | 32 | 261 | 4 | 2.70.150.10 | |
| Domain | VWFA | 1.01e-03 | 82 | 261 | 6 | PS50234 | |
| Domain | Acyl-CoA_Oxase/DH_cen-dom | 1.08e-03 | 15 | 261 | 3 | IPR006091 | |
| Domain | AcylCoA_DH/oxidase_NM_dom | 1.08e-03 | 15 | 261 | 3 | IPR009100 | |
| Domain | Acyl-CoA_dh_M | 1.08e-03 | 15 | 261 | 3 | PF02770 | |
| Domain | Neural_cell_adh | 1.15e-03 | 4 | 261 | 2 | IPR009138 | |
| Domain | G2F | 1.15e-03 | 4 | 261 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 1.15e-03 | 4 | 261 | 2 | PS50993 | |
| Domain | GFP | 1.15e-03 | 4 | 261 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 1.15e-03 | 4 | 261 | 2 | IPR006605 | |
| Domain | VWA | 1.15e-03 | 84 | 261 | 6 | SM00327 | |
| Domain | Laminin_G | 1.28e-03 | 58 | 261 | 5 | IPR001791 | |
| Domain | EGF_CA | 1.30e-03 | 86 | 261 | 6 | PF07645 | |
| Domain | TYR_PHOSPHATASE_1 | 1.30e-03 | 86 | 261 | 6 | PS00383 | |
| Domain | EGF_2 | GAS6 ITGB2 NELL2 HMCN2 HSPG2 FAT4 TNC ADAM29 THBS3 OIT3 HMCN1 | 1.31e-03 | 265 | 261 | 11 | PS01186 |
| Domain | Integrin_alpha_C_CS | 1.32e-03 | 16 | 261 | 3 | IPR018184 | |
| Domain | AcylCo_DH/oxidase_C | 1.32e-03 | 16 | 261 | 3 | IPR009075 | |
| Domain | TYR_PHOSPHATASE_dom | 1.38e-03 | 87 | 261 | 6 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 1.38e-03 | 87 | 261 | 6 | PS50056 | |
| Domain | PTPc_motif | 1.39e-03 | 59 | 261 | 5 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.39e-03 | 59 | 261 | 5 | IPR003595 | |
| Domain | ATPase_P-typ_cyto_domN | 1.39e-03 | 35 | 261 | 4 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 1.54e-03 | 36 | 261 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 1.54e-03 | 36 | 261 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.54e-03 | 36 | 261 | 4 | PS00154 | |
| Domain | TPR-like_helical_dom | TRANK1 PEX5 GPSM2 ANAPC5 OGT RPAP3 LRPPRC UNC45B VPS41 IFT122 | 1.68e-03 | 233 | 261 | 10 | IPR011990 |
| Domain | ATPase_P-typ_transduc_dom_A | 1.71e-03 | 37 | 261 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.71e-03 | 37 | 261 | 4 | PF00122 | |
| Domain | EGF | 1.79e-03 | 235 | 261 | 10 | SM00181 | |
| Domain | EGF_3 | 1.79e-03 | 235 | 261 | 10 | PS50026 | |
| Domain | - | 1.84e-03 | 92 | 261 | 6 | 3.90.190.10 | |
| Domain | Integrin_alpha-2 | 1.88e-03 | 18 | 261 | 3 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 1.88e-03 | 18 | 261 | 3 | PS00242 | |
| Domain | Integrin_alpha2 | 1.88e-03 | 18 | 261 | 3 | PF08441 | |
| Domain | Integrin_alpha | 1.88e-03 | 18 | 261 | 3 | IPR000413 | |
| Domain | Groucho_enhance | 1.89e-03 | 5 | 261 | 2 | IPR009146 | |
| Domain | TLE_N | 1.89e-03 | 5 | 261 | 2 | PF03920 | |
| Domain | Groucho/TLE_N | 1.89e-03 | 5 | 261 | 2 | IPR005617 | |
| Domain | VWFC_2 | 1.89e-03 | 38 | 261 | 4 | PS50184 | |
| Domain | Ig_V-set | 1.99e-03 | 199 | 261 | 9 | IPR013106 | |
| Domain | - | 2.17e-03 | 95 | 261 | 6 | 2.60.120.200 | |
| Domain | Int_alpha | 2.21e-03 | 19 | 261 | 3 | SM00191 | |
| Domain | VWC_out | 2.21e-03 | 19 | 261 | 3 | SM00215 | |
| Domain | Int_alpha_beta-p | 2.21e-03 | 19 | 261 | 3 | IPR013519 | |
| Domain | TPR | 2.26e-03 | 129 | 261 | 7 | SM00028 | |
| Domain | Laminin_G_2 | 2.29e-03 | 40 | 261 | 4 | PF02210 | |
| Domain | Prot-tyrosine_phosphatase-like | 2.67e-03 | 99 | 261 | 6 | IPR029021 | |
| Domain | VWF_A | 2.67e-03 | 99 | 261 | 6 | IPR002035 | |
| Domain | TPR_repeat | 2.68e-03 | 133 | 261 | 7 | IPR019734 | |
| Domain | VWF_dom | 2.75e-03 | 42 | 261 | 4 | IPR001007 | |
| Domain | ASX_HYDROXYL | 2.80e-03 | 100 | 261 | 6 | PS00010 | |
| Pubmed | SERPINA3 PSAP MYCBP2 OBSCN CLASP2 BIRC6 DNTTIP2 DES STRADB SNX6 ANKRD28 FBXO32 MYO18B AKAP6 HSPG2 ELP1 CHORDC1 ANKRD50 CSRP3 LRPPRC FSTL1 ATP2A1 PALLD MYBPC2 | 1.38e-12 | 497 | 269 | 24 | 23414517 | |
| Pubmed | LRRC24 PSG6 OBSCN JAM2 PTPRD PTPRF PTPRS ROBO3 ADGRA3 IGSF3 CNTN4 HMCN1 LRIG1 CNTN3 SIGLEC1 | 2.83e-12 | 162 | 269 | 15 | 25826454 | |
| Pubmed | A2M SERPINA3 NCAM1 ITGB2 JAM2 PTPRF PTPRS MPO CNTN4 HSPG2 TNC APOH ORM1 ORM2 FSTL1 CNTN3 | 2.14e-10 | 257 | 269 | 16 | 16335952 | |
| Pubmed | MYCBP2 ATAD5 TMEM126B CCDC18 CLASP2 RRBP1 ME2 NCDN DNTTIP2 ITPR3 SNX6 GLUD1 ASPM ANKRD28 BOP1 EIF2AK3 WDR62 ANK3 RPAP3 NSF PIK3R3 OTUB1 ELP1 ZNF622 SPG11 CHORDC1 PDHX THOC5 LIFR LRPPRC IGF2R ZNF451 MTR IFT122 TYW1 ZNF512 HSPA14 | 4.14e-10 | 1487 | 269 | 37 | 33957083 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | GADD45B TRPM4 ERCC2 LRRC24 MYCBP2 SREBF1 OBSCN SLCO4A1 CLASP2 ZNF236 BIRC6 ITPR3 PTPRF PTPRS ZER1 IGSF3 GAREM1 HSPG2 FAM89A FBXL14 NSD1 LMTK2 RALGAPA2 IGF2R SETD5 ZNRF1 PCNX1 ZFYVE26 HAS3 | 1.19e-08 | 1105 | 269 | 29 | 35748872 |
| Pubmed | ERCC2 DCDC1 ATAD5 ZNF460 GAS6 RSRC2 BRWD3 DNTTIP2 NELL2 HMCN2 ACAD11 BRCA1 ASPM PEX5 ANKRD28 BRD1 SGF29 ZDHHC13 ANAPC5 WDR62 OGT PIK3R3 RALGAPA2 PDHX RAD50 SETD5 MTR LRRC8B SIGLEC1 | 1.48e-08 | 1116 | 269 | 29 | 31753913 | |
| Pubmed | MYCBP2 ATAD5 CCDC18 CLASP2 BIRC6 ITPR3 CEP350 PTPN3 PTPN6 PTPRD PTPRF SNX6 PTPRS ANKRD28 ANK3 RPAP3 PIK3R3 FBXL14 LMTK2 ELP1 NBEA GSK3B MTMR4 IGF2R TLE3 STX16 ZNF512 | 5.83e-08 | 1049 | 269 | 27 | 27880917 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 TRPM4 MYCBP2 TRPM2 SRC GAS6 OBSCN CLASP2 RRBP1 ZNF236 ME2 ADCY1 NCDN BRWD3 PTPRS RIN2 ARID5B ZDHHC13 OGT ANK3 PIK3R3 TECTA TMEM255B EVA1C LRPPRC SETD5 TLE3 VPS41 IFT122 GREB1 ZNF512 CPNE7 | 2.03e-07 | 1489 | 269 | 32 | 28611215 |
| Pubmed | A2M SREBF1 SLCO4A1 RRBP1 NCDN ACAD11 ANKRD28 ANAPC5 OGT RPAP3 DHX40 NOA1 ELP1 ANKRD50 MAP3K6 MTR IFT122 MTREX HSD17B11 PALLD | 2.10e-07 | 650 | 269 | 20 | 38777146 | |
| Pubmed | 2.39e-07 | 8 | 269 | 4 | 28637841 | ||
| Pubmed | KNTC1 MYCBP2 SLCO4A1 CLASP2 RSRC2 RRBP1 BIRC6 CEP350 KANK1 PEX5 ANKRD28 PRR14L WDR62 RPAP3 SPG11 MTMR4 IGF2R ZNF792 ZNF451 MTR TYW1 | 3.34e-07 | 733 | 269 | 21 | 34672954 | |
| Pubmed | 4.58e-07 | 3 | 269 | 3 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 4.58e-07 | 3 | 269 | 3 | 33656439 | |
| Pubmed | 4.58e-07 | 3 | 269 | 3 | 9784606 | ||
| Pubmed | Developmental expression of PAM (protein associated with MYC) in the rodent brain. | 4.58e-07 | 3 | 269 | 3 | 12036515 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 4.58e-07 | 3 | 269 | 3 | 31985401 | |
| Pubmed | LRRC24 MYCBP2 SRC NCAM1 CLASP2 NCDN NEDD4 PTPRD PLPPR4 PTPRS PEX5 ANKRD28 CNTN4 CACNA1E CACNB4 OGT ANK3 NSF NSD1 NBEA GSK3B RAD50 LRPPRC IGF2R | 5.85e-07 | 963 | 269 | 24 | 28671696 | |
| Pubmed | Human colostrum: identification of minor proteins in the aqueous phase by proteomics. | 5.97e-07 | 162 | 269 | 10 | 16502470 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | A2M PGM3 ITPR3 PTPN3 PTPN6 PTPRD ACAD11 PTPRF SNX6 PTPRS GLUD1 ANKRD28 BOP1 MPO OGT NSF DHX40 OTUB1 ELP1 ANKRD50 RAD50 LRPPRC MTMR4 ATP2A1 | 7.15e-07 | 974 | 269 | 24 | 28675297 |
| Pubmed | 1.11e-06 | 11 | 269 | 4 | 25624497 | ||
| Pubmed | 1.11e-06 | 11 | 269 | 4 | 11792727 | ||
| Pubmed | 1.25e-06 | 25 | 269 | 5 | 8858346 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | CYC1 PSAP CLASP2 CEP350 BRCA1 SNX6 GCLC ASPM ANKRD28 ANAPC5 CNTN4 RPAP3 OTUB1 ZNF622 THOC5 TLE4 PALLD HSPA14 BORA | 1.43e-06 | 670 | 269 | 19 | 22990118 |
| Pubmed | 1.65e-06 | 12 | 269 | 4 | 9183385 | ||
| Pubmed | Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity. | 1.82e-06 | 4 | 269 | 3 | 19789387 | |
| Pubmed | 1.82e-06 | 4 | 269 | 3 | 8524829 | ||
| Pubmed | 1.82e-06 | 4 | 269 | 3 | 34504132 | ||
| Pubmed | 1.82e-06 | 4 | 269 | 3 | 14967925 | ||
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 1.87e-06 | 27 | 269 | 5 | 31541017 | |
| Pubmed | Proteome-wide characterization of N-glycosylation events by diagonal chromatography. | 2.32e-06 | 77 | 269 | 7 | 16944957 | |
| Pubmed | A2M PSAP SPINT1 MYCBP2 RRBP1 NEDD4 KANK1 PTPRF ANKRD28 BRD1 HSPG2 ANK3 OTUB1 MTMR4 ZNF451 VPS41 STX16 | 4.29e-06 | 591 | 269 | 17 | 15231748 | |
| Pubmed | 4.36e-06 | 249 | 269 | 11 | 30097533 | ||
| Pubmed | 4.52e-06 | 5 | 269 | 3 | 10777529 | ||
| Pubmed | 4.52e-06 | 5 | 269 | 3 | 1379092 | ||
| Pubmed | 4.52e-06 | 5 | 269 | 3 | 23292839 | ||
| Pubmed | 4.52e-06 | 5 | 269 | 3 | 22357843 | ||
| Pubmed | Genomic organization and chromosomal localization of the mouse IKBKAP gene. | 4.52e-06 | 5 | 269 | 3 | 11722848 | |
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 7.69e-06 | 17 | 269 | 4 | 19727691 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | PSAP MYCBP2 SREBF1 ITGA2 RRBP1 ITGAV NELL2 PTPRF SNX6 PTPRS ZDHHC13 EIF2AK3 ADGRA3 WDR62 IGSF3 HSPG2 FAT4 CHORDC1 LIFR THBS3 IGF2R FSTL1 TYW1 PALLD FRMD5 | 8.19e-06 | 1201 | 269 | 25 | 35696571 |
| Pubmed | 9.00e-06 | 6 | 269 | 3 | 19273906 | ||
| Pubmed | 9.83e-06 | 18 | 269 | 4 | 28272472 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.09e-05 | 97 | 269 | 7 | 27559042 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | A2M SERPINA3 PSAP SPINT1 GAS6 ITGAV NEDD4 DES ATP8A1 PTPRD PTPRS MPO HSPG2 FAT4 OTUB1 APOH LIFR ORM1 ORM2 IGF2R FSTL1 HMCN1 CPNE7 | 1.15e-05 | 1070 | 269 | 23 | 23533145 |
| Pubmed | 1.54e-05 | 20 | 269 | 4 | 22687584 | ||
| Pubmed | 1.57e-05 | 7 | 269 | 3 | 12376545 | ||
| Pubmed | Three-axis classification of mouse lung mesenchymal cells reveals two populations of myofibroblasts. | 1.57e-05 | 7 | 269 | 3 | 35302583 | |
| Pubmed | 1.57e-05 | 7 | 269 | 3 | 29073098 | ||
| Pubmed | 1.90e-05 | 71 | 269 | 6 | 12754519 | ||
| Pubmed | CYC1 NCAM1 CLASP2 ITGA2 RRBP1 NCDN ATP8A1 PLPPR4 FGD4 PTPRS GLUD1 GLUD2 SYP METAP2 CACNB4 ASRGL1 OGT ANK3 NSF TNC ELP1 NBEA PDHX GSK3B LRPPRC LRIG1 SLC4A10 | 2.03e-05 | 1431 | 269 | 27 | 37142655 | |
| Pubmed | Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway. | 2.49e-05 | 8 | 269 | 3 | 28826662 | |
| Pubmed | 2.49e-05 | 8 | 269 | 3 | 19638463 | ||
| Pubmed | 2.49e-05 | 8 | 269 | 3 | 8647855 | ||
| Pubmed | 2.49e-05 | 8 | 269 | 3 | 37591863 | ||
| Pubmed | 2.49e-05 | 8 | 269 | 3 | 15370361 | ||
| Pubmed | 2.59e-05 | 152 | 269 | 8 | 19578796 | ||
| Pubmed | 3.14e-05 | 47 | 269 | 5 | 15172686 | ||
| Pubmed | Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. | 3.14e-05 | 47 | 269 | 5 | 14760718 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ERCC2 MYLK SRC GAS6 RRBP1 DNTTIP2 CHUK PTPN3 ACAD11 RIN2 BOP1 DDX60L ANAPC5 METAP2 MAP3K6 GSK3B RAD50 ULK3 CCNE2 PALLD | 3.19e-05 | 910 | 269 | 20 | 36736316 |
| Pubmed | 3.71e-05 | 9 | 269 | 3 | 10337627 | ||
| Pubmed | 3.71e-05 | 9 | 269 | 3 | 7508415 | ||
| Pubmed | Ebf2 is a selective marker of brown and beige adipogenic precursor cells. | 3.71e-05 | 9 | 269 | 3 | 25197048 | |
| Pubmed | Dynamic expression patterns of ECM molecules in the developing mouse olfactory pathway. | 3.71e-05 | 9 | 269 | 3 | 18570250 | |
| Pubmed | 3.90e-05 | 25 | 269 | 4 | 29475039 | ||
| Pubmed | 3.98e-05 | 209 | 269 | 9 | 36779422 | ||
| Pubmed | ERCC2 RRBP1 ITPR3 IVD STRADB BRCA1 RIN2 ANKRD28 ANK3 NSF PIK3R3 THOC5 LRPPRC IGF2R CCNE2 MTREX | 4.03e-05 | 634 | 269 | 16 | 34591612 | |
| Pubmed | 5.27e-05 | 10 | 269 | 3 | 9184108 | ||
| Pubmed | 5.27e-05 | 10 | 269 | 3 | 22027834 | ||
| Pubmed | Genetic nomenclature for loci controlling surface antigens of mouse hemopoietic cells. | 5.65e-05 | 53 | 269 | 5 | 1431091 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 26146906 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 15253437 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 18332254 | ||
| Pubmed | The Drosophila ZNRF1/2 homologue, detour, interacts with HOPS complex and regulates autophagy. | 5.96e-05 | 2 | 269 | 2 | 38360932 | |
| Pubmed | Selective binding of coumarin enantiomers to human alpha1-acid glycoprotein genetic variants. | 5.96e-05 | 2 | 269 | 2 | 16290938 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 28621566 | ||
| Pubmed | Calmodulin-stimulated adenylyl cyclase gene deletion affects morphine responses. | 5.96e-05 | 2 | 269 | 2 | 16914643 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 21850020 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 15157739 | ||
| Pubmed | Src kinase mediates UV-induced TRPV1 trafficking into cell membrane in HaCaT keratinocytes. | 5.96e-05 | 2 | 269 | 2 | 29080357 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 32078638 | ||
| Pubmed | Orosomucoid-1 Arises as a Shared Altered Protein in Two Models of Multiple Sclerosis. | 5.96e-05 | 2 | 269 | 2 | 37949310 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 15745964 | ||
| Pubmed | Comparison of alpha-1-acid glycoprotein isoforms from healthy and cancer patients by capillary IEF. | 5.96e-05 | 2 | 269 | 2 | 17987628 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 14724275 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 27732084 | ||
| Pubmed | TRPV1 in brain is involved in acetaminophen-induced antinociception. | 5.96e-05 | 2 | 269 | 2 | 20862299 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 23618877 | ||
| Pubmed | Integrin αv in the mechanical response of osteoblast lineage cells. | 5.96e-05 | 2 | 269 | 2 | 24726648 | |
| Pubmed | Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes. | 5.96e-05 | 2 | 269 | 2 | 28927749 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 36063901 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 28911206 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 22415874 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 4711474 | ||
| Pubmed | Calcium-stimulated adenylyl cyclases are critical modulators of neuronal ethanol sensitivity. | 5.96e-05 | 2 | 269 | 2 | 15843614 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 18222416 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 25264156 | ||
| Pubmed | Knockout of hyaluronan synthase 1, but not 3, impairs formation of the retrocalcaneal bursa. | 5.96e-05 | 2 | 269 | 2 | 29672913 | |
| Pubmed | Molecular basis of human glutamate dehydrogenase regulation under changing energy demands. | 5.96e-05 | 2 | 269 | 2 | 15578726 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 25722380 | ||
| Pubmed | Induction of excitatory and inhibitory presynaptic differentiation by GluD1. | 5.96e-05 | 2 | 269 | 2 | 22138648 | |
| Pubmed | Obscurin is a ligand for small ankyrin 1 in skeletal muscle. | 5.96e-05 | 2 | 269 | 2 | 12631729 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | MYLK LRRC24 PDGFRA FSTL5 OBSCN NCAM1 JAM2 HMCN2 PTPRD PTPRF PTPRS ROBO3 ADGRA3 CNTN4 HSPG2 MXRA5 HMCN1 LRIG1 CNTN3 SIGLEC1 PALLD MYBPC2 | 2.43e-18 | 161 | 193 | 22 | 593 |
| GeneFamily | Fibronectin type III domain containing | MYLK OBSCN NCAM1 PTPRD PTPRF PTPRS ROBO3 CNTN4 TNC LIFR CNTN3 MYBPC2 | 1.51e-07 | 160 | 193 | 12 | 555 |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | PDGFRA NCAM1 ITGA2 ITGAE ITGAV ITGB2 JAM2 ABCG2 IFITM1 LIFR CD3G IGF2R SIGLEC1 IL5RA | 8.92e-05 | 394 | 193 | 14 | 471 |
| GeneFamily | CD molecules|Integrin alpha subunits | 8.68e-04 | 18 | 193 | 3 | 1160 | |
| GeneFamily | Lipocalins | 1.02e-03 | 19 | 193 | 3 | 631 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 1.11e-03 | 5 | 193 | 2 | 1336 | |
| GeneFamily | RAB like GTPases | 1.11e-03 | 5 | 193 | 2 | 394 | |
| GeneFamily | Ankyrin repeat domain containing | KANK1 TRANK1 ANKRD28 ZDHHC13 TRPV1 ANK1 ANK3 ANKRD50 ANKRD55 | 1.20e-03 | 242 | 193 | 9 | 403 |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.38e-03 | 21 | 193 | 3 | 813 | |
| GeneFamily | Glycosyltransferase family 2 | 1.65e-03 | 6 | 193 | 2 | 428 | |
| GeneFamily | Fibulins | 3.04e-03 | 8 | 193 | 2 | 556 | |
| GeneFamily | Transient receptor potential cation channels | 3.22e-03 | 28 | 193 | 3 | 249 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 3.57e-03 | 29 | 193 | 3 | 754 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 4.32e-03 | 31 | 193 | 3 | 81 | |
| GeneFamily | Immunoglobulin like domain containing | 4.75e-03 | 193 | 193 | 7 | 594 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 4.82e-03 | 10 | 193 | 2 | 53 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 KNTC1 MYCBP2 RSRC2 ITGAV CEP350 BRCA1 SNX10 ASPM METAP2 GAREM1 ASRGL1 RPAP3 SPG11 CHORDC1 RAD50 FSTL1 VPS41 MTR MTREX PALLD | 4.05e-06 | 656 | 266 | 21 | M18979 |
| Coexpression | GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP | A2M GART GAS6 RRBP1 ITGB2 SNX10 ADGRA3 ASRGL1 RPAP3 DHX40 ORM1 | 6.85e-06 | 200 | 266 | 11 | M8844 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.35e-05 | 176 | 266 | 10 | M39223 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.74e-05 | 191 | 266 | 10 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.42e-05 | 196 | 266 | 10 | M3008 | |
| Coexpression | GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN | 3.42e-05 | 196 | 266 | 10 | M7672 | |
| Coexpression | GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN | ZNF460 MBL2 DNTTIP2 PLPPR4 GCLC ANXA9 AKAP6 PIK3R3 ATP10D LRIG1 | 3.73e-05 | 198 | 266 | 10 | M8355 |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_DN | 3.73e-05 | 198 | 266 | 10 | M9747 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN | GADD45B PDGFRA NCDN SNX10 IFITM1 IFITM2 IGF2R FSTL1 PCNX1 SIGLEC1 | 4.06e-05 | 200 | 266 | 10 | M9533 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 5.28e-05 | 166 | 266 | 9 | M6826 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | GPR137 PDGFRA GART OBSCN NCAM1 PTPN3 PTPRD SYP BOP1 FGL1 GAREM1 AKAP6 CACNA1E ANK3 LMTK2 SCLY TECTA ALX1 CCNE2 TLE4 IFT122 CDH4 MYBPC2 | 5.97e-05 | 909 | 266 | 23 | M41018 |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 6.37e-05 | 211 | 266 | 10 | M12225 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN | 6.64e-05 | 171 | 266 | 9 | M8820 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_T4 | 7.34e-05 | 100 | 266 | 7 | MM1215 | |
| Coexpression | EPPERT_PROGENITOR | 8.62e-05 | 138 | 266 | 8 | M19232 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 PRMT8 ATAD5 CCDC18 RSRC2 BIRC6 ME2 DNTTIP2 JAM2 KANK1 BRCA1 ASPM ANKRD28 MPO RPAP3 METTL5 CCNE2 TLE3 CDH4 | 2.70e-05 | 532 | 256 | 19 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | MYO1A PDGFRA NEXMIF GAS6 NCAM1 ME2 CEP350 TRANK1 PTPRD PTPRF RIN2 FGL1 ADGRA3 CNTN4 FAT4 OGT PIK3R3 IFITM1 RND3 HMCN1 MTR HSD17B11 PALLD | 3.46e-05 | 740 | 256 | 23 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | KNTC1 ATAD5 NEDD4 BRCA1 FGD4 ASPM ABCG2 MPO IFITM1 NBEA IFITM2 OIT3 FSTL1 HMCN1 CCNE2 BORA | 4.15e-05 | 410 | 256 | 16 | GSM791122_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | MYCBP2 FSTL5 CLASP2 CSMD3 BIRC6 CEP350 ATP8A1 FGD4 LRRTM4 ASPM ADAMTS20 METAP2 AKAP6 CNTN4 FAT4 OGT TNC NSD1 GSK3B RND3 LIFR SETD5 ZNF451 CNTN3 | 5.79e-05 | 818 | 256 | 24 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | BRINP3 PRMT8 ATAD5 NCAM1 JAM2 CEP350 NELL2 ATP8A1 PTPRD BRCA1 FGD4 LRRTM4 ASPM SYP GPSM2 ZER1 CA3 ASRGL1 PIK3R3 RALGAPA2 RND3 CCNE2 LRRC8B CDH4 FRMD5 | 8.55e-05 | 893 | 256 | 25 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | PSAP TMPRSS13 NEXMIF GART GAS6 CSMD3 ME2 BRWD3 PTPN3 NELL2 TRANK1 FGD4 RIN2 FGL1 CNTN4 FAT4 PIK3R3 IFITM1 ATP10D PHAF1 HMCN1 MTR HSD17B11 | 9.48e-05 | 791 | 256 | 23 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 9.93e-05 | 188 | 256 | 10 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | PRMT8 ATAD5 GART SLCO4A1 ME2 BRWD3 DNTTIP2 PTPN6 BRCA1 GCLC LRRTM4 SNX10 ANKRD28 ZDHHC13 WDR62 ASRGL1 RPAP3 NOA1 IFITM1 SCLY RAD50 LINS1 THBS3 RABL2A METTL5 ALX1 SETD5 CCNE2 TLE4 RAVER2 GREB1 MTREX CDH4 | 1.18e-04 | 1371 | 256 | 33 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.18e-04 | 192 | 256 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | BDP1 PRMT8 ATAD5 CCDC18 SLCO4A1 JAM2 NELL2 ATP8A1 BRCA1 FGD4 ASPM WDR62 RPAP3 APOH CCNE2 CDH4 FRMD5 | 1.24e-04 | 498 | 256 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | MYLK PDGFRA NCAM1 CLASP2 BIRC6 BRWD3 CEP350 PTPRD ARID5B ASPM SNX31 METAP2 IGSF3 CNTN4 FAT4 ASRGL1 OGT NSD1 GSK3B RND3 LIFR SETD5 CCNE2 | 1.37e-04 | 811 | 256 | 23 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | PRMT8 ATAD5 NCAM1 RSRC2 ME2 DNTTIP2 JAM2 CEP350 ATP8A1 PTPRD BRCA1 FGD4 ASPM ANKRD28 GPSM2 FAT4 NBEA RABL2A TLE4 CDH4 | 1.41e-04 | 654 | 256 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | BRINP3 PRMT8 ATAD5 SRC FAAH JAM2 NELL2 PTPRD BRCA1 FGD4 LRRTM4 ASPM SYP GPSM2 ZER1 CA3 ASRGL1 PIK3R3 RALGAPA2 RND3 EVA1C CCNE2 CCDC68 LRRC8B CDH4 FRMD5 | 1.61e-04 | 986 | 256 | 26 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | KNTC1 MYO1A TMPRSS13 PDGFRA ATAD5 NEXMIF CCDC18 NCAM1 PGM3 TRANK1 PTPRD PTPRF ASPM FGL1 ADGRA3 CNTN4 TNC ANKRD50 RND3 HMCN1 RAVER2 PALLD | 1.67e-04 | 768 | 256 | 22 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | PDGFRA ATP8A1 PTPRD RIN2 LRRTM4 ADAMTS20 FAT4 IFITM1 NBEA RND3 LRIG1 ZNF451 | 2.09e-04 | 288 | 256 | 12 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_500 | 2.26e-04 | 134 | 256 | 8 | gudmap_developingGonad_e18.5_ovary_500_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | GADD45B SPINT1 MYCBP2 SLCO4A1 BIRC6 FAAH ITPR3 CEP350 ATP8A1 PTPRF FGD4 PKHD1 SNX31 ANXA9 OGT ANK3 LIFR LINS1 ALX1 VPS41 ACSM2A CDH4 | 2.30e-04 | 786 | 256 | 22 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M GADD45B SERPINA3 MYLK PDGFRA PTPRD PLPPR4 PTPRS CA3 FAT4 FSTL1 HMCN1 PALLD | 2.53e-10 | 197 | 269 | 13 | 94a9603cbd3516fbcce871909693b88f20d41713 |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | A2M MYLK PDGFRA ITGA2 PTPRD PLPPR4 PTPRS CA3 FAT4 TNC FSTL1 HMCN1 PALLD | 3.06e-10 | 200 | 269 | 13 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | A2M MYLK PDGFRA ITGA2 PTPRD PLPPR4 PTPRS CA3 FAT4 TNC FSTL1 HMCN1 PALLD | 3.06e-10 | 200 | 269 | 13 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | A2M MYLK PDGFRA ITGA2 PTPRD PLPPR4 PTPRS CA3 FAT4 TNC FSTL1 HMCN1 PALLD | 3.06e-10 | 200 | 269 | 13 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M GAS6 SLCO4A1 JAM2 HSPG2 ASRGL1 IFITM1 IFITM2 RALGAPA2 TMEM255B EVA1C LIFR | 2.77e-09 | 195 | 269 | 12 | 53b83e16b350100b1d5791a9c42bd98e37cbc0af |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | CYC1 OBSCN NCAM1 DES FBXO32 MYO18B AKAP6 CSRP3 UNC45B ATP2A1 PALLD MYBPC2 | 3.11e-09 | 197 | 269 | 12 | 44e49943d62bfe622b40ad0460093d31540544df |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MYLK PDGFRA MYCBP2 PTPRD GPSM2 CNTN4 TNC DNAI3 RND3 LIFR FSTL1 PALLD | 3.48e-09 | 199 | 269 | 12 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | MYLK PDGFRA MYCBP2 RRBP1 PTPRD ARID5B GPSM2 TNC DNAI3 RND3 LIFR FSTL1 | 3.69e-09 | 200 | 269 | 12 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | UNC93A CSMD3 OTOGL PKHD1 USP29 TECTA CNTN3 SIGLEC1 LGR6 ATP12A ACSM2B | 4.58e-09 | 162 | 269 | 11 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NUGGC BRINP3 MYLK PDGFRA NCAM1 DES FAT4 TNC HMCN1 CNTN3 LGR6 | 1.46e-08 | 181 | 269 | 11 | b116c68393d8836bac080f81a8fcbeb52e0403e7 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M OBSCN CSMD3 TRANK1 PTPRD OTOGL PKHD1 ADAMTS20 FAT4 ANK1 HMCN1 | 1.73e-08 | 184 | 269 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M OBSCN CSMD3 TRANK1 PTPRD OTOGL PKHD1 ADAMTS20 FAT4 ANK1 HMCN1 | 1.73e-08 | 184 | 269 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M OBSCN CSMD3 TRANK1 PTPRD OTOGL PKHD1 ADAMTS20 FAT4 ANK1 HMCN1 | 1.73e-08 | 184 | 269 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 1.83e-08 | 185 | 269 | 11 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RBM44 UNC93A CSMD3 OTOGL PKHD1 USP29 TECTA CNTN3 ATP12A ACSM2B | 2.00e-08 | 145 | 269 | 10 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | MYLK PDGFRA NCAM1 PTPRD PTPRS TNC IFITM1 IFITM2 RND3 IGF2R PALLD | 2.28e-08 | 189 | 269 | 11 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | OBSCN ABCG2 DDX60L MYO18B EIF2AK3 FHIP1A GAREM1 AKAP6 ANK3 CSRP3 PALLD | 2.41e-08 | 190 | 269 | 11 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-08 | 191 | 269 | 11 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-08 | 191 | 269 | 11 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | PRMT8 NEXMIF PTPRD FHIP1A CA3 GAREM1 CNTN4 ANK3 NBEA LRIG1 CNTN3 | 2.83e-08 | 193 | 269 | 11 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M GAS6 SLCO4A1 JAM2 HSPG2 ASRGL1 IFITM1 IFITM2 RALGAPA2 EVA1C LIFR | 2.83e-08 | 193 | 269 | 11 | 682ce63b73a7d02eef240673db67058d7507f744 |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M GAS6 SLCO4A1 JAM2 HSPG2 ASRGL1 IFITM1 IFITM2 RALGAPA2 EVA1C LIFR | 2.83e-08 | 193 | 269 | 11 | c0f0052c24b7fe9e21d2bc6c38047a8e755f87b6 |
| ToppCell | 10x5'-Liver|World / Manually curated celltypes from each tissue | SERPINA3 NCAM1 ITGB2 EOMES FGL1 IFITM1 IFITM2 APOH ORM1 ORM2 SLC4A10 | 2.83e-08 | 193 | 269 | 11 | d010d47d763c99e68aede59345392f2a8c77d7ac |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PTPN3 KANK1 PTPRD FGD4 PKHD1 FHIP1A GAREM1 CNTN4 ANK3 ACSM2A ACSM2B | 2.98e-08 | 194 | 269 | 11 | 7002937e8903e037332a215d00fbc7c7843b33f2 |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M GAS6 SLCO4A1 JAM2 ASRGL1 PIK3R3 IFITM1 IFITM2 EVA1C LIFR CCDC68 | 3.68e-08 | 198 | 269 | 11 | b11d21aa96a0c91e958ae7ed8fd56546aeaebb91 |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M GAS6 SLCO4A1 JAM2 ASRGL1 PIK3R3 IFITM1 IFITM2 EVA1C LIFR CCDC68 | 3.68e-08 | 198 | 269 | 11 | 605ef5b61750226b93bca48166d8a1f6450e80e0 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CSMD3 GGT5 ARID5B FAT4 MXRA5 TNC IFITM1 IFITM2 RND3 FSTL1 CCDC68 | 3.68e-08 | 198 | 269 | 11 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PDGFRA RRBP1 DES ARID5B CNTN4 MXRA5 TNC IFITM1 RND3 FSTL1 PALLD | 3.87e-08 | 199 | 269 | 11 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.87e-08 | 199 | 269 | 11 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PDGFRA RRBP1 PTPRD ARID5B CNTN4 MXRA5 TNC DNAI3 RND3 FSTL1 PALLD | 3.87e-08 | 199 | 269 | 11 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PDGFRA RRBP1 DES ARID5B CNTN4 MXRA5 TNC IFITM1 RND3 FSTL1 PALLD | 3.87e-08 | 199 | 269 | 11 | ba586690f88fd051f449753bfe7603a2cb431782 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.87e-08 | 199 | 269 | 11 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | A2M GAS6 JAM2 HSPG2 ASRGL1 PIK3R3 IFITM1 IFITM2 TMEM255B EVA1C LIFR | 4.07e-08 | 200 | 269 | 11 | cd3c638961144a2fc91c437a173cc37c7452fa74 |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | A2M BRINP3 MYLK PDGFRA GAS6 TNC RND3 FSTL1 HMCN1 CCDC68 PALLD | 4.07e-08 | 200 | 269 | 11 | 251fd2923f108cd2086961d897244b392c32ad54 |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 1.13e-07 | 174 | 269 | 10 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 1.25e-07 | 176 | 269 | 10 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.31e-07 | 188 | 269 | 10 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.43e-07 | 189 | 269 | 10 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-07 | 189 | 269 | 10 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-07 | 190 | 269 | 10 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | GADD45B DEPDC4 MYO18B EIF2AK3 FHIP1A GAREM1 AKAP6 ANK3 ETNPPL CSRP3 | 2.55e-07 | 190 | 269 | 10 | 3729648a17093b438398b82e32bbccc3af7b8c5d |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-07 | 190 | 269 | 10 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-07 | 191 | 269 | 10 | f932980baa032748857cb367a55c37dd975c693e | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-07 | 146 | 269 | 9 | 74009a2921359a8352afbaea8c325a3743622543 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-07 | 146 | 269 | 9 | cb19f2bb6832d11fe69b670df49eac096a378a9d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | ITPR3 PTPN3 KANK1 ATP8A1 FHIP1A GAREM1 CNTN4 CACNB4 ASRGL1 ANK3 | 2.81e-07 | 192 | 269 | 10 | cc9911e182a289779a2612bc213daae5607689e7 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.81e-07 | 192 | 269 | 10 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | NEXMIF GAS6 SREBF1 ATP8A1 PTPRF GCLC ANK3 RALGAPA2 PHAF1 CCDC68 | 2.95e-07 | 193 | 269 | 10 | 1fdfe08b0c82248545c29b504ac259b093fde29b |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | NEXMIF GAS6 SREBF1 ATP8A1 PTPRF GCLC ANK3 RALGAPA2 PHAF1 CCDC68 | 2.95e-07 | 193 | 269 | 10 | 5f90e3e526032d82d9dc7e0813fe79ca28dc0719 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-07 | 193 | 269 | 10 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-07 | 194 | 269 | 10 | f4c9fc53ae31d58096906d9305b0b4082512a7e9 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | BRINP3 OBSCN NCAM1 OTOGL MYO18B AKAP6 ANK3 DNAI3 PALLD FRMD5 | 3.09e-07 | 194 | 269 | 10 | 89812fb164065041357bb37a3c2d87028ec3de4e |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.09e-07 | 194 | 269 | 10 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-07 | 194 | 269 | 10 | ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-07 | 195 | 269 | 10 | 841fde528ecb293e07b5e00e499d1e9f0b0dce14 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.24e-07 | 195 | 269 | 10 | 2414b158dc7bdec43a9671544bfb7ffc5f5168fd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-07 | 195 | 269 | 10 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | ITGA2 NELL2 ANKRD28 FBXO32 ANK3 ANKRD55 LRIG1 SLC4A10 ZNRF1 PCNX1 | 3.24e-07 | 195 | 269 | 10 | 6687e579582d7a239bee80846de0cf827a6f6a62 |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CSMD3 GGT5 ARID5B FAT4 IFITM1 IFITM2 RND3 FSTL1 GALNT9 CCDC68 | 3.40e-07 | 196 | 269 | 10 | 85507488f83d8f71b3ee2ad5e5aa0b6ad6193873 |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.40e-07 | 196 | 269 | 10 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-07 | 196 | 269 | 10 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-07 | 196 | 269 | 10 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.56e-07 | 197 | 269 | 10 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.56e-07 | 197 | 269 | 10 | 236a40eb6c08e1d179cf0fb5450b032975c5f6b6 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.56e-07 | 197 | 269 | 10 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.73e-07 | 198 | 269 | 10 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.73e-07 | 198 | 269 | 10 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | distal-1-Endothelial-Bronchial_Vessel_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | A2M GAS6 SLCO4A1 JAM2 HSPG2 PIK3R3 IFITM1 TMEM255B EVA1C LIFR | 3.73e-07 | 198 | 269 | 10 | 5cd81fe1a21c0e1a7f0d5a62ddf8e422b05aedc7 |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | SLCO4A1 PRND JAM2 HSPG2 ASRGL1 PIK3R3 IFITM2 TMEM255B LIFR CCDC68 | 3.91e-07 | 199 | 269 | 10 | edb68a4f622a494f22fd7b25bc40ae0d58456cdb |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M SLCO4A1 JAM2 HSPG2 ASRGL1 PIK3R3 IFITM1 IFITM2 EVA1C LIFR | 3.91e-07 | 199 | 269 | 10 | 6e3a226ebba023e3e909d7a7188137da4f1fd7fc |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.91e-07 | 199 | 269 | 10 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.91e-07 | 199 | 269 | 10 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.91e-07 | 199 | 269 | 10 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SLCO4A1 PRND JAM2 HSPG2 ASRGL1 PIK3R3 IFITM2 TMEM255B LIFR CCDC68 | 3.91e-07 | 199 | 269 | 10 | 45f9c03d2ed2d98d66086fb0251bd24e30c6f775 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.91e-07 | 199 | 269 | 10 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.91e-07 | 199 | 269 | 10 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SLCO4A1 PRND JAM2 HSPG2 ASRGL1 PIK3R3 IFITM2 TMEM255B LIFR CCDC68 | 3.91e-07 | 199 | 269 | 10 | 448dd5a27d57627468c6b8347f1b6b1005aea004 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.91e-07 | 199 | 269 | 10 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 3.91e-07 | 199 | 269 | 10 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | A2M JAM2 HSPG2 ASRGL1 PIK3R3 IFITM1 IFITM2 TMEM255B EVA1C LIFR | 3.91e-07 | 199 | 269 | 10 | 258d59cf811bf1668ffbb5f18f961021f660de62 |
| ToppCell | distal-Endothelial-Artery-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | A2M SLCO4A1 JAM2 HSPG2 ASRGL1 PIK3R3 IFITM1 EVA1C LIFR PALLD | 3.91e-07 | 199 | 269 | 10 | 3788f3218356aaaa10684e48d63757037f8a3a3c |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.91e-07 | 199 | 269 | 10 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.10e-07 | 200 | 269 | 10 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | A2M SERPINA3 PDGFRA ITGA2 PTPRS ARID5B TNC FSTL1 HMCN1 PALLD | 4.10e-07 | 200 | 269 | 10 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | A2M SLCO4A1 JAM2 HSPG2 ASRGL1 PIK3R3 RALGAPA2 EVA1C LIFR CCDC68 | 4.10e-07 | 200 | 269 | 10 | 84e145619a500530f42ed0fe72468ae95f4cbf1e |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.10e-07 | 200 | 269 | 10 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | A2M SLCO4A1 JAM2 HSPG2 ASRGL1 RALGAPA2 TMEM255B EVA1C LIFR CCDC68 | 4.10e-07 | 200 | 269 | 10 | cb00760ae75c30b1cb8526534aabd4ffc7c21000 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.10e-07 | 200 | 269 | 10 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 4.10e-07 | 200 | 269 | 10 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | A2M SERPINA3 PDGFRA ITGA2 PTPRS ARID5B TNC FSTL1 HMCN1 PALLD | 4.10e-07 | 200 | 269 | 10 | cc6062dac07916c29091fc6bee2b864d29e6525b |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | A2M SERPINA3 PDGFRA ITGA2 PTPRS ARID5B TNC FSTL1 HMCN1 PALLD | 4.10e-07 | 200 | 269 | 10 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 |
| ToppCell | distal-Endothelial-Vein-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | A2M SLCO4A1 JAM2 HSPG2 ASRGL1 PIK3R3 RALGAPA2 MAP3K6 EVA1C LIFR | 4.10e-07 | 200 | 269 | 10 | ff88d28162e0231d5dac0e0c6bec98fa8da58a23 |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 4.10e-07 | 200 | 269 | 10 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | A2M SERPINA3 MYLK PDGFRA PTPRD PLPPR4 MXRA5 FSTL1 HMCN1 PALLD | 4.10e-07 | 200 | 269 | 10 | e504570fd7eec1524c401b1cfa9d10822d80d994 |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.10e-07 | 200 | 269 | 10 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | A2M SLCO4A1 JAM2 HSPG2 ASRGL1 PIK3R3 IFITM1 IFITM2 TMEM255B LIFR | 4.10e-07 | 200 | 269 | 10 | a1f5684fe3815642159dd201b7ecc39f09bee1e8 |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.10e-07 | 200 | 269 | 10 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.10e-07 | 200 | 269 | 10 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.50e-07 | 162 | 269 | 9 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.21e-07 | 164 | 269 | 9 | 583dda853cee9491dbdcb228c23d8deadc20eb08 | |
| Computational | Genes in the cancer module 412. | 1.08e-06 | 13 | 170 | 5 | MODULE_412 | |
| Computational | Genes in the cancer module 275. | 3.54e-06 | 16 | 170 | 5 | MODULE_275 | |
| Computational | Genes in the cancer module 128. | 1.45e-04 | 97 | 170 | 8 | MODULE_128 | |
| Computational | Genes in the cancer module 79. | 1.67e-04 | 99 | 170 | 8 | MODULE_79 | |
| Computational | Immune response. | 1.80e-04 | 100 | 170 | 8 | MODULE_170 | |
| Computational | Adhesion molecules. | 3.93e-04 | 141 | 170 | 9 | MODULE_122 | |
| Drug | hydroxyl radicals | CYC1 MYCBP2 GART GAS6 PRND ITGA2 ME2 ENOPH1 ACOX2 GGT5 IVD PTPN3 PTPN6 ATP8A1 PTPRD PTPRF KIF2B GCLC PTPRS GLUD1 GLUD2 PLIN1 ANAPC5 CA3 MPO CPA6 ASRGL1 NSF USP29 PDHX ATP10D CD3G GSTK1 CCNE2 MTR ATP12A ATP2A1 | 7.93e-07 | 1341 | 263 | 37 | CID000000961 |
| Drug | Sialic acids | A2M SERPINA3 PSAP MBL2 NCAM1 GGT5 PTPN3 GLUD1 GLUD2 OGT APOH ORM1 ORM2 SIGLEC1 HAS1 | 7.35e-06 | 329 | 263 | 15 | CID000349960 |
| Drug | N-acetylhexosamine | A2M MBL2 GAS6 NCAM1 ITGA2 ITGAE ITGAV ITGB2 GLUD1 GLUD2 MPO OGT APOH LIFR ORM1 ORM2 IGF2R HAS1 | 1.07e-05 | 472 | 263 | 18 | CID000000899 |
| Drug | sporidesmin | 1.15e-05 | 13 | 263 | 4 | CID000099596 | |
| Drug | phylloerythrin | 1.15e-05 | 13 | 263 | 4 | CID005480977 | |
| Drug | ginsenoside Re | 1.79e-05 | 71 | 263 | 7 | ctd:C049864 | |
| Drug | 3'-sialyl LewisX | SERPINA3 NCAM1 RRBP1 ITGB2 EOMES DES MPO NSD1 ORM1 ORM2 CNTN3 | 1.96e-05 | 197 | 263 | 11 | CID000643990 |
| Drug | Proxyphylline [603-00-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | TRPM4 ATAD5 SRC RRBP1 BRCA1 GAREM1 PIK3R3 SCLY BORCS8 THBS3 NEK11 | 1.96e-05 | 197 | 263 | 11 | 5993_DN |
| Drug | PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A | GPR137 TRPM4 PDGFRA ZER1 OTUB1 UBOX5 THOC5 VPS41 PCNX1 IFT122 NEK11 | 2.15e-05 | 199 | 263 | 11 | 6410_UP |
| Drug | Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; MCF7; HT_HG-U133A | SERPINA3 ATAD5 RRBP1 ARIH2 WDR62 OTUB1 LINS1 METTL5 TLE3 TLE4 GREB1 | 2.15e-05 | 199 | 263 | 11 | 7215_DN |
| Drug | C75; Up 200; 10uM; MCF7; HT_HG-U133A | PDGFRA TRPM2 DES TRANK1 ADAMTS20 ANK1 TECTA ANKRD55 ORM1 METTL5 CPNE7 | 2.15e-05 | 199 | 263 | 11 | 6394_UP |
| Drug | Nadolol [42200-33-9]; Down 200; 13uM; HL60; HT_HG-U133A | ITPR3 IVD ZER1 ABCG2 CACNB4 ANK3 IFITM1 UBOX5 THOC5 METTL5 VPS41 | 2.25e-05 | 200 | 263 | 11 | 3020_DN |
| Drug | type-IV | A2M SERPINA3 SPINT1 MBL2 NCAM1 PTPN3 GLUD1 GLUD2 ORM1 ORM2 IFT122 SIGLEC1 HAS1 | 2.58e-05 | 281 | 263 | 13 | CID000000906 |
| Drug | AC1MZP2J | 2.97e-05 | 6 | 263 | 3 | CID003950037 | |
| Drug | diazonium-1-H-tetrazole | 2.97e-05 | 6 | 263 | 3 | CID000188312 | |
| Drug | oxazepam | 3.27e-05 | 53 | 263 | 6 | CID000004616 | |
| Drug | Etiocobalamin | 4.23e-05 | 177 | 263 | 10 | CID006450878 | |
| Drug | albizziin | 4.69e-05 | 18 | 263 | 4 | CID000092891 | |
| Drug | orthovanadate | PDGFRA SRC ADCY1 ADCY8 PGM3 PTPN3 PTPN6 PTPRD ACAD11 PTPRS ABCG2 NSF TNC PIK3R3 VPS41 ATP2A1 | 5.10e-05 | 435 | 263 | 16 | CID000061672 |
| Drug | AC1L1B5W | 5.15e-05 | 7 | 263 | 3 | CID000001296 | |
| Drug | 2-oxoglutaconic acid | 5.15e-05 | 7 | 263 | 3 | CID006443759 | |
| Drug | N-acryloxysuccinimide | 5.15e-05 | 7 | 263 | 3 | CID000181508 | |
| Drug | perfluoro-n-nonanoic acid | 5.46e-05 | 114 | 263 | 8 | ctd:C101816 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.60e-05 | 183 | 263 | 10 | 5613_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | BRINP3 RSRC2 CEP350 PTPN3 KANK1 ARID5B ASPM EIF2AK3 PIK3R3 SETD5 | 5.86e-05 | 184 | 263 | 10 | 2321_DN |
| Drug | salinomycin | 6.14e-05 | 185 | 263 | 10 | ctd:C010327 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | BRINP3 ATAD5 CLASP2 RIN2 ARID5B ANAPC5 WDR62 ANK3 TLE3 NEK11 | 7.02e-05 | 188 | 263 | 10 | 6451_DN |
| Drug | Quercetine dihydrate [6151-25-3]; Up 200; 11.8uM; HL60; HT_HG-U133A | 7.34e-05 | 189 | 263 | 10 | 2499_UP | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | BRINP3 ARID5B IGSF3 PIK3R3 BORCS8 LRIG1 CCNE2 PCIF1 PCNX1 GREB1 | 7.34e-05 | 189 | 263 | 10 | 5248_DN |
| Drug | Daunorubicin hydrochloride [23541-50-6]; Down 200; 7uM; MCF7; HT_HG-U133A | GADD45B RSRC2 CEP350 ARID5B BRD1 PIK3R3 RND3 CCNE2 TLE3 ZFYVE26 | 7.67e-05 | 190 | 263 | 10 | 4983_DN |
| Drug | tallow | SREBF1 ITGB2 PGM3 SNX10 FGL1 CA3 RPAP3 ETNPPL CSRP3 RND3 LIFR ORM2 | 7.73e-05 | 270 | 263 | 12 | ctd:C013698 |
| Drug | Nessler's reagent | 8.18e-05 | 8 | 263 | 3 | CID000024542 | |
| Drug | mono-(2-ethylhexyl)phthalate | CYC1 RBM44 NUP210L SRC SREBF1 CLASP2 PTPRD PKHD1 ADAMTS20 PLIN1 MPO ANK1 GSK3B RND3 LRIG1 SLC4A10 CNTN3 ATP12A FRMD5 MYBPC2 | 8.74e-05 | 658 | 263 | 20 | ctd:C016599 |
| Drug | platensimycin | 8.78e-05 | 63 | 263 | 6 | CID006857724 | |
| Drug | 2,4,4'-trichlorobiphenyl | KNTC1 BRINP3 PRMT8 DCDC1 TMPRSS13 PDGFRA SPINT1 ATAD5 SLCO4A1 RSRC2 CSMD3 BRWD3 EOMES PTPN3 NELL2 TRANK1 FGD4 PTPRS ASPM SYP FHIP1A CNTN4 OGT ANK1 NSF ETNPPL RALGAPA2 ORM1 UNC45B SLC4A10 GREB1 LGR6 BORA | 9.23e-05 | 1411 | 263 | 33 | ctd:C081766 |
| Drug | ST021200; Down 200; 10uM; PC3; HT_HG-U133A | ATAD5 ADCY1 ANAPC5 METAP2 WDR62 GAREM1 ATG2B UBOX5 CCNE2 TLE3 | 9.52e-05 | 195 | 263 | 10 | 7493_DN |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; PC3; HT_HG-U133A | TRPM4 PDGFRA ATAD5 NCDN METAP2 ANK3 ATP10D BORCS8 STX16 CPNE7 | 9.52e-05 | 195 | 263 | 10 | 1214_UP |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | GADD45B ATAD5 RRBP1 IVD ANAPC5 TRPV1 IFITM1 UBOX5 BORCS8 NEK11 | 9.52e-05 | 195 | 263 | 10 | 5213_DN |
| Drug | Trifluridine [70-00-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 9.52e-05 | 195 | 263 | 10 | 5819_UP | |
| Drug | pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A | 9.93e-05 | 196 | 263 | 10 | 7083_DN | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.04e-04 | 197 | 263 | 10 | 5482_UP | |
| Drug | FK-506; Up 200; 1uM; MCF7; HG-U133A | GPR137 GADD45B ERCC2 IVD MXRA5 ASRGL1 PIK3R3 SCLY IGF2R TLE3 | 1.04e-04 | 197 | 263 | 10 | 284_UP |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.04e-04 | 197 | 263 | 10 | 2796_DN | |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Down 200; 12.6uM; HL60; HT_HG-U133A | 1.04e-04 | 197 | 263 | 10 | 3009_DN | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.04e-04 | 197 | 263 | 10 | 2318_UP | |
| Drug | indole-3-acetyl-l-valine | 1.05e-04 | 65 | 263 | 6 | CID000446641 | |
| Drug | Ethionamide [536-33-4]; Up 200; 24uM; HL60; HT_HG-U133A | 1.08e-04 | 198 | 263 | 10 | 2495_UP | |
| Drug | Meticrane [1084-65-7]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 263 | 10 | 5984_UP | |
| Drug | Trimethadione [127-48-0]; Down 200; 28uM; MCF7; HT_HG-U133A | GPR137 CEP350 RIN2 ARIH2 GAREM1 TRPV1 UBOX5 BORCS8 PCIF1 HSD17B11 | 1.08e-04 | 198 | 263 | 10 | 2846_DN |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; HL60; HT_HG-U133A | 1.08e-04 | 198 | 263 | 10 | 2570_DN | |
| Drug | Sulfadoxine [2447-57-6]; Down 200; 12.8uM; PC3; HT_HG-U133A | GPR137 GADD45B GAS6 DES BRCA1 ARIH2 ANAPC5 UBOX5 ATP10D PCIF1 | 1.08e-04 | 198 | 263 | 10 | 5852_DN |
| Drug | indomethacin, USP; Down 200; 100uM; PC3; HG-U133A | 1.08e-04 | 198 | 263 | 10 | 452_DN | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 263 | 10 | 5444_DN | |
| Drug | Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.13e-04 | 199 | 263 | 10 | 2756_DN | |
| Drug | Rgd Peptide | PSG6 SRC NCAM1 ITGA2 ITGAE ITGAV ITGB2 CNTN4 TNC IFITM2 THBS3 | 1.13e-04 | 239 | 263 | 11 | CID000104802 |
| Drug | AC1N4HBY | 1.22e-04 | 9 | 263 | 3 | CID004128835 | |
| Drug | 2 HR | 1.24e-04 | 67 | 263 | 6 | CID006398363 | |
| Drug | phenyltriethoxysilane | 1.33e-04 | 2 | 263 | 2 | CID000013075 | |
| Drug | norlorcainide | 1.33e-04 | 2 | 263 | 2 | CID000162188 | |
| Drug | G-3SH | 1.33e-04 | 2 | 263 | 2 | CID000174237 | |
| Drug | iodoacetyldiethylstilbestrol | 1.33e-04 | 2 | 263 | 2 | CID006455327 | |
| Drug | methylmercuric bromide | 1.33e-04 | 2 | 263 | 2 | CID000068175 | |
| Drug | 5-methylisophthalate | 1.33e-04 | 2 | 263 | 2 | CID000068137 | |
| Drug | carocainide | 1.33e-04 | 2 | 263 | 2 | CID000071970 | |
| Drug | 2,4,4-trimethyl-2-pentanol | 1.33e-04 | 2 | 263 | 2 | CID000094740 | |
| Drug | x 1 s | 1.33e-04 | 2 | 263 | 2 | CID000409694 | |
| Drug | selenolanthionine | 1.33e-04 | 2 | 263 | 2 | CID000193608 | |
| Drug | 3-phenylindole | 1.33e-04 | 2 | 263 | 2 | CID000096502 | |
| Drug | NSC240899 | 1.33e-04 | 43 | 263 | 5 | CID000047627 | |
| Drug | NeuGc | 1.35e-04 | 68 | 263 | 6 | CID000123802 | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | KNTC1 BRINP3 PRMT8 DCDC1 TMPRSS13 PDGFRA SPINT1 ATAD5 SLCO4A1 RSRC2 CSMD3 BRWD3 EOMES PTPN3 NELL2 TRANK1 FGD4 PTPRS ASPM SYP FHIP1A CNTN4 OGT ANK1 NSF ETNPPL RALGAPA2 ORM1 UNC45B SLC4A10 GREB1 LGR6 BORA | 1.37e-04 | 1441 | 263 | 33 | ctd:C009828 |
| Drug | Dichloroacetic Acid | A2M GADD45B TRPM4 NUGGC LRRC24 SREBF1 SLCO4A1 UNC93A PRND ADCY1 ACAD11 GCLC ABCG2 FGL1 MPO RALGAPA2 ANKRD55 ATP10D SDR9C7 LIFR ORM1 ORM2 HSD17B11 NEK11 MYBPC2 | 1.54e-04 | 967 | 263 | 25 | ctd:D003999 |
| Disease | bipolar disorder (is_implicated_in) | 5.20e-06 | 29 | 261 | 5 | DOID:3312 (is_implicated_in) | |
| Disease | sensorineural hearing loss (is_implicated_in) | 1.01e-05 | 33 | 261 | 5 | DOID:10003 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | SRC OBSCN FAAH NEDD4 EOMES DES PTPRD BRCA1 OTOGL ABCG2 ANAPC5 AKAP6 ANK1 NOA1 ELP1 TECTA MAP3K6 THOC5 THBS3 UNC45B TLE3 MTR ZFYVE26 LGR6 HSPA14 | 1.16e-05 | 1074 | 261 | 25 | C0006142 |
| Disease | Manic Disorder | 4.00e-05 | 71 | 261 | 6 | C0024713 | |
| Disease | Intellectual Disability | BRWD3 PGM3 BRCA1 WDR62 AKAP6 CACNA1E NSF NSD1 NBEA UBR7 PDHX LINS1 METTL5 SLC4A10 | 5.05e-05 | 447 | 261 | 14 | C3714756 |
| Disease | pancreatic cancer (is_implicated_in) | 6.43e-05 | 112 | 261 | 7 | DOID:1793 (is_implicated_in) | |
| Disease | Manic | 6.82e-05 | 78 | 261 | 6 | C0338831 | |
| Disease | Depression, Bipolar | 7.32e-05 | 79 | 261 | 6 | C0005587 | |
| Disease | X-21319 measurement | 7.79e-05 | 2 | 261 | 2 | EFO_0800807 | |
| Disease | cognitive function measurement, self reported educational attainment | MYCBP2 BIRC6 IVD PTPRF PKHD1 AKAP6 CACNA1E ZNF19 LRPPRC MTMR4 SLC4A10 AFG1L | 8.51e-05 | 355 | 261 | 12 | EFO_0004784, EFO_0008354 |
| Disease | cystic fibrosis (is_implicated_in) | 8.94e-05 | 27 | 261 | 4 | DOID:1485 (is_implicated_in) | |
| Disease | azoospermia (implicated_via_orthology) | 8.94e-05 | 27 | 261 | 4 | DOID:14227 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | FSTL5 MBL2 TRPM2 NCAM1 ME2 ADCY8 NEDD4 TRANK1 BRD1 CNTN4 ANK3 GSK3B MTR AFG1L | 1.00e-04 | 477 | 261 | 14 | C0005586 |
| Disease | metabolite measurement | SREBF1 UNC93A FAAH IVD ABCG2 SGF29 ASRGL1 ANK3 PDHX ATP10D BCO1 IGF2R PCIF1 ZNF512 ACSM2A | 1.56e-04 | 560 | 261 | 15 | EFO_0004725 |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 1.77e-04 | 59 | 261 | 5 | EFO_0001663, MONDO_0005148 | |
| Disease | Colorectal Carcinoma | ERCC2 FSTL5 SRC OBSCN CSMD3 ADCY8 NCDN PTPRD PTPRS PKHD1 ABCG2 AKAP6 MPO CNTN4 ADAM29 LIFR LGR6 | 1.91e-04 | 702 | 261 | 17 | C0009402 |
| Disease | coffee consumption measurement | 2.29e-04 | 182 | 261 | 8 | EFO_0006781 | |
| Disease | X-11478 measurement | 2.32e-04 | 3 | 261 | 2 | EFO_0021242 | |
| Disease | Schwartz-Jampel syndrome | 2.32e-04 | 3 | 261 | 2 | cv:C0036391 | |
| Disease | fascioliasis (biomarker_via_orthology) | 2.32e-04 | 3 | 261 | 2 | DOID:885 (biomarker_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 2.69e-04 | 100 | 261 | 6 | C0010606 | |
| Disease | Acute kidney injury | 2.84e-04 | 101 | 261 | 6 | C2609414 | |
| Disease | Kidney Failure, Acute | 2.84e-04 | 101 | 261 | 6 | C0022660 | |
| Disease | Acute Kidney Insufficiency | 2.84e-04 | 101 | 261 | 6 | C1565662 | |
| Disease | QRS duration | NCAM1 PTPRD ANKRD28 FAT4 ANKRD50 PDHX HMCN1 LRIG1 PALLD MYBPC2 | 3.49e-04 | 298 | 261 | 10 | EFO_0005055 |
| Disease | cognitive function measurement | KNTC1 TMPRSS13 NUP210L NCAM1 CSMD3 BIRC6 IVD PTPRD PTPRF FGD4 PKHD1 MYO18B ADGRA3 AKAP6 CNTN4 CACNA1E NSF NBEA ZNF19 LRPPRC CCDC68 SLC4A10 CDH4 CPNE7 MYBPC2 AFG1L | 4.50e-04 | 1434 | 261 | 26 | EFO_0008354 |
| Disease | vasculitis (is_implicated_in) | 4.62e-04 | 4 | 261 | 2 | DOID:865 (is_implicated_in) | |
| Disease | ADP-ribose pyrophosphatase, mitochondrial measurement | 4.62e-04 | 4 | 261 | 2 | EFO_0801349 | |
| Disease | peripheral vascular disease (is_implicated_in) | 4.62e-04 | 4 | 261 | 2 | DOID:341 (is_implicated_in) | |
| Disease | Congenital myotonia | 4.62e-04 | 4 | 261 | 2 | cv:CN295225 | |
| Disease | Liver Cirrhosis, Experimental | A2M PDGFRA SREBF1 ITGB2 ACOX2 IVD KANK1 PTPRD ZDHHC13 CA3 FAM89A TRPV1 IFITM1 NBEA ATP10D IGF2R FSTL1 | 5.83e-04 | 774 | 261 | 17 | C0023893 |
| Disease | creatinine measurement | DCDC1 OBSCN BIRC6 BRWD3 PTPN3 ARID5B PKHD1 ABCG2 ANXA9 DHX40 NSD1 ETNPPL SCLY CHORDC1 ULK3 THBS3 IGF2R LRIG1 ACSM2B CPNE7 | 5.98e-04 | 995 | 261 | 20 | EFO_0004518 |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 7.15e-04 | 216 | 261 | 8 | EFO_0007925, EFO_0007927 | |
| Disease | total blood protein measurement | SERPINA3 RRBP1 EOMES PTPN3 ARID5B PKHD1 IFITM2 ANKRD55 TLE3 TLE4 LRRC8B SIGLEC1 | 7.17e-04 | 449 | 261 | 12 | EFO_0004536 |
| Disease | 3-hydroxyhexanoate measurement | 7.66e-04 | 5 | 261 | 2 | EFO_0800378 | |
| Disease | electrocardiography | MYCBP2 OBSCN DES PTPN3 TRANK1 HMCN2 FBXO32 MYO18B LRIG1 TLE3 PCNX1 PALLD FRMD5 | 9.58e-04 | 530 | 261 | 13 | EFO_0004327 |
| Disease | cardiac troponin I measurement | 1.01e-03 | 176 | 261 | 7 | EFO_0010071 | |
| Disease | frailty measurement | 1.06e-03 | 23 | 261 | 3 | EFO_0009885 | |
| Disease | verbal-numerical reasoning measurement | 1.12e-03 | 131 | 261 | 6 | EFO_0008394 | |
| Disease | indoleacetoylcarnitine measurement | 1.14e-03 | 6 | 261 | 2 | EFO_0800106 | |
| Disease | childhood absence epilepsy (biomarker_via_orthology) | 1.14e-03 | 6 | 261 | 2 | DOID:1825 (biomarker_via_orthology) | |
| Disease | CEROID LIPOFUSCINOSIS, NEURONAL, 6 | 1.14e-03 | 6 | 261 | 2 | C1866282 | |
| Disease | serine protease inhibitor Kazal-type 2 measurement | 1.14e-03 | 6 | 261 | 2 | EFO_0802054 | |
| Disease | serum gamma-glutamyl transferase measurement | NUP210L CSMD3 ITGB2 PTPN3 TRANK1 GCLC PKHD1 ZER1 ANXA9 ANAPC5 PIK3R3 LMTK2 ZNRF2 PDHX EVA1C PCIF1 SIGLEC1 AFG1L | 1.40e-03 | 914 | 261 | 18 | EFO_0004532 |
| Disease | Profound Mental Retardation | 1.52e-03 | 139 | 261 | 6 | C0020796 | |
| Disease | Mental deficiency | 1.52e-03 | 139 | 261 | 6 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 1.52e-03 | 139 | 261 | 6 | C0025363 | |
| Disease | ascending aortic diameter | 1.58e-03 | 140 | 261 | 6 | EFO_0021787 | |
| Disease | COVID-19, obesity | 1.59e-03 | 7 | 261 | 2 | EFO_0001073, MONDO_0100096 | |
| Disease | psoriasis (implicated_via_orthology) | 1.59e-03 | 7 | 261 | 2 | DOID:8893 (implicated_via_orthology) | |
| Disease | muscular atrophy (implicated_via_orthology) | 1.59e-03 | 7 | 261 | 2 | DOID:767 (implicated_via_orthology) | |
| Disease | thrombocytopenia (is_implicated_in) | 1.71e-03 | 27 | 261 | 3 | DOID:1588 (is_implicated_in) | |
| Disease | irritable bowel syndrome symptom measurement | 1.74e-03 | 58 | 261 | 4 | EFO_0021536 | |
| Disease | serum metabolite measurement | UNC93A FAAH IVD ARID5B ABCG2 SGF29 CNTN4 CACNA1E ASRGL1 PIK3R3 ATP10D BCO1 LRPPRC IGF2R PCIF1 VPS41 ACSM2A ACSM2B | 2.01e-03 | 945 | 261 | 18 | EFO_0005653 |
| Disease | microcephaly (is_implicated_in) | 2.11e-03 | 8 | 261 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | Leigh syndrome | 2.11e-03 | 8 | 261 | 2 | cv:C0023264 | |
| Disease | coronary restenosis (is_implicated_in) | 2.11e-03 | 8 | 261 | 2 | DOID:4247 (is_implicated_in) | |
| Disease | central nervous system cancer, glioma | 2.11e-03 | 29 | 261 | 3 | EFO_0000326, EFO_0005543 | |
| Disease | sodium measurement | 2.26e-03 | 103 | 261 | 5 | EFO_0009282 | |
| Disease | cortical thickness | A2M DCDC1 MYCBP2 NUP210L SREBF1 NCAM1 ME2 NELL2 PTPRF PKHD1 ADAMTS20 SNX31 SGF29 AKAP6 HSPG2 NSF THBS3 ALX1 SETD5 HAS3 | 2.27e-03 | 1113 | 261 | 20 | EFO_0004840 |
| Disease | thoracic aortic aneurysm | 2.33e-03 | 30 | 261 | 3 | EFO_0004282 | |
| Disease | triacylglycerol 50:4 measurement | 2.33e-03 | 30 | 261 | 3 | EFO_0010411 | |
| Disease | coronary artery calcification | BDP1 RBM44 FSTL5 PTPN3 ARID5B CACNA1E ANK3 ADAM29 ZNRF2 PCIF1 CDH4 | 2.38e-03 | 450 | 261 | 11 | EFO_0004723 |
| Disease | Schizophrenia | SREBF1 NCAM1 ME2 PTPN6 BRCA1 GCLC SYP SNX31 BRD1 ANK3 ETNPPL APOH GSK3B LIFR FSTL1 CCDC68 MTR | 2.39e-03 | 883 | 261 | 17 | C0036341 |
| Disease | blood viscosity | 2.56e-03 | 31 | 261 | 3 | EFO_0004301 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 2.56e-03 | 31 | 261 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | smoking cessation | 2.57e-03 | 325 | 261 | 9 | EFO_0004319 | |
| Disease | Pancreatic carcinoma, familial | 2.69e-03 | 9 | 261 | 2 | C2931038 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 2.69e-03 | 9 | 261 | 2 | C0085548 | |
| Disease | familial atrial fibrillation | 2.72e-03 | 156 | 261 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.72e-03 | 156 | 261 | 6 | C2585653 | |
| Disease | Paroxysmal atrial fibrillation | 2.72e-03 | 156 | 261 | 6 | C0235480 | |
| Disease | breast carcinoma (is_marker_for) | 2.81e-03 | 66 | 261 | 4 | DOID:3459 (is_marker_for) | |
| Disease | myocardial infarction (implicated_via_orthology) | 2.81e-03 | 66 | 261 | 4 | DOID:5844 (implicated_via_orthology) | |
| Disease | Uterine leiomyoma, breast carcinoma | 2.81e-03 | 32 | 261 | 3 | EFO_0000305, HP_0000131 | |
| Disease | asthma (is_implicated_in) | 2.81e-03 | 157 | 261 | 6 | DOID:2841 (is_implicated_in) | |
| Disease | Atrial Fibrillation | 3.09e-03 | 160 | 261 | 6 | C0004238 | |
| Disease | uric acid measurement | DCDC1 CCDC18 BIRC6 GLUD1 ANKRD28 ABCG2 GAREM1 CNTN4 FAT4 LMTK2 ANKRD50 LRIG1 ACSM2B | 3.27e-03 | 610 | 261 | 13 | EFO_0004761 |
| Disease | Nonorganic psychosis | 3.30e-03 | 69 | 261 | 4 | C0349204 | |
| Disease | protein eva-1 homolog C measurement | 3.35e-03 | 10 | 261 | 2 | EFO_0801942 | |
| Disease | response to carboplatin, response to antineoplastic agent | 3.35e-03 | 10 | 261 | 2 | GO_0097327, GO_0097328 | |
| Disease | 3-methyl-2-oxobutyrate measurement | 3.35e-03 | 10 | 261 | 2 | EFO_0021020 | |
| Disease | complement factor H-related protein 3 measurement | 4.04e-03 | 169 | 261 | 6 | EFO_0600056 | |
| Disease | coagulation factor XA measurement | 4.07e-03 | 11 | 261 | 2 | EFO_0020266 | |
| Disease | Macrocephaly | 4.07e-03 | 11 | 261 | 2 | C0221355 | |
| Disease | epilepsy, response to xenobiotic stimulus | 4.07e-03 | 11 | 261 | 2 | EFO_0000474, GO_0009410 | |
| Disease | Occupational Diseases | 4.07e-03 | 11 | 261 | 2 | C0028797 | |
| Disease | late onset Parkinson's disease (is_implicated_in) | 4.07e-03 | 11 | 261 | 2 | DOID:0060892 (is_implicated_in) | |
| Disease | ovary epithelial cancer (is_implicated_in) | 4.07e-03 | 11 | 261 | 2 | DOID:2152 (is_implicated_in) | |
| Disease | Rheumatoid Arthritis | 4.65e-03 | 174 | 261 | 6 | C0003873 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 4.85e-03 | 12 | 261 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | Gastrointestinal Diseases | 4.85e-03 | 12 | 261 | 2 | C0017178 | |
| Disease | hyperinsulinism (is_implicated_in) | 4.85e-03 | 12 | 261 | 2 | DOID:2018 (is_implicated_in) | |
| Disease | Functional Gastrointestinal Disorders | 4.85e-03 | 12 | 261 | 2 | C0559031 | |
| Disease | Cholera Infantum | 4.85e-03 | 12 | 261 | 2 | C1565321 | |
| Disease | phenylacetylglutamine measurement | 4.85e-03 | 12 | 261 | 2 | EFO_0021013 | |
| Disease | Mouth Diseases | 4.85e-03 | 12 | 261 | 2 | C0026636 | |
| Disease | adult respiratory distress syndrome (is_implicated_in) | 4.85e-03 | 12 | 261 | 2 | DOID:11394 (is_implicated_in) | |
| Disease | Disproportionate short stature | 4.88e-03 | 77 | 261 | 4 | C0878659 | |
| Disease | Lung diseases | 5.11e-03 | 78 | 261 | 4 | C0024115 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CQDSSVNYGITKVEG | 71 | Q15699 | |
| AGDNVICGSYDSKLV | 631 | Q14137 | |
| AGANTASETCYKELN | 511 | Q9UKF5 | |
| ISKATLDCLNGDYNV | 551 | P40145 | |
| NNGKTCRVVFDDTYD | 61 | P07451 | |
| VGKTAAVYACAQELG | 1136 | Q96QE3 | |
| KSLDSNDSGVYTSAC | 626 | O95936 | |
| LVTKLSASCTYEGEN | 426 | Q99424 | |
| SYIACNSEGEFICKE | 261 | Q76B58 | |
| ELISCIENGNYAKAA | 891 | O95696 | |
| LDDYQEVSSLCVTKG | 2116 | A6H8Y1 | |
| FVELTKQASCSGDEY | 191 | O95394 | |
| YQEDGSVLLTCDAEA | 36 | P09693 | |
| KCSYTEDAQCIDGTI | 306 | P02749 | |
| ACLEKVDISSTEGYD | 176 | Q9NR09 | |
| SCDEDYVLQGAKSIT | 511 | Q7Z407 | |
| SSKDTEKECIGNYVD | 1321 | Q15878 | |
| IVFEDSGCDNASSKE | 806 | Q9NZJ5 | |
| CTVVELKYTGNASAL | 261 | P01011 | |
| AVALDCKGNVAYATS | 171 | Q7L266 | |
| KSDGCHILYSDENIT | 716 | Q8IWK6 | |
| AASCYDVQIIDDKGN | 386 | Q08AH3 | |
| EDITGTTKLVYANEC | 1186 | P16157 | |
| TYKDCFTGSDAVDVV | 86 | Q8N2C3 | |
| ETKDNYTLVVVCSDA | 2426 | Q6V0I7 | |
| TTKEQLGEFYEALDC | 151 | P19652 | |
| ATCTGEEYLVKQGID | 606 | Q9UNQ0 | |
| AVLKEYCNTVQLDSG | 266 | Q8WV93 | |
| KLQEFAYVTDGACSE | 206 | O96020 | |
| TDCVYSLLNKGANVD | 666 | O15084 | |
| NVTKSDAGSYTCIAT | 466 | Q8IWV2 | |
| NYENTLIAAGSCDKV | 231 | Q6RI45 | |
| FTCLTYKESEGALNE | 61 | O95376 | |
| KVFGIECSSISDYSE | 136 | Q9NR22 | |
| LYAGVKVDCADADSR | 631 | Q9ULJ7 | |
| YDDESGKTCVHIAAA | 226 | Q3KP44 | |
| VGVCYTEDEAKELAA | 136 | P08574 | |
| SSATYGKSCQDLQRE | 221 | Q9H2F9 | |
| QNASSVKDAYIECTA | 201 | Q8IWG1 | |
| VVDCSNREDIYSSAK | 91 | Q8NBQ5 | |
| CVESAAYKAVNALQS | 346 | Q8N4T0 | |
| AVKTNVSYCGALDED | 96 | O00305 | |
| KTTSAVYDVENCIDI | 3331 | Q8IZT6 | |
| AKTTEECLAYFGVSE | 6 | O14983 | |
| EKLSVCYFTNSGSEA | 101 | Q8TBG4 | |
| VYCDETADESSGINV | 196 | Q96BY7 | |
| CYIETSNLDGETNLK | 181 | Q9Y2Q0 | |
| CETALDQGYSETKAF | 1401 | Q9P241 | |
| NSQEDYKAVVSLCGG | 136 | P59510 | |
| CSIQRDEDSYVINGK | 521 | Q709F0 | |
| VIGDSAKYDVENCLA | 551 | P01023 | |
| GSESQHALEKCIAYS | 621 | Q9HCJ3 | |
| VVELGNSGYEVKCAS | 216 | Q6ZP01 | |
| ATCNYETKSENGVKV | 191 | Q96L73 | |
| LENGITESCATSYSK | 1441 | Q96L73 | |
| IRDVKESDQGAYTCE | 466 | P98160 | |
| QLSSYEDKLFDVCGS | 621 | Q92878 | |
| YGDTLISQESCEKSE | 776 | Q9Y5H2 | |
| SGLKQSEAESCYINI | 196 | P26045 | |
| ASNYELSDNAGCKEV | 196 | Q14573 | |
| YDADDNVKIICLGDS | 16 | Q9UBK7 | |
| YDADDNVKIICLGDS | 16 | Q9UNT1 | |
| LVAKCQVASAASYDQ | 666 | Q9UJX4 | |
| TVKDSGDYECAARQA | 281 | P16234 | |
| DKEITSANYAGVCTS | 1281 | M0R2J8 | |
| SANYAGVCTSSVIKE | 1286 | M0R2J8 | |
| DDAKYTCKAVNSLGE | 1876 | Q15746 | |
| KDRAVEAQSCYSLGN | 276 | P81274 | |
| KEAYQIACLGVTDTD | 631 | Q9HBG6 | |
| DATESKYDISICGCV | 546 | Q8NG48 | |
| AGDTTVLQYDDICKI | 236 | P50579 | |
| QGEKVSDAVETYNIC | 346 | Q86VH4 | |
| DVKIDDAGVYSCTAQ | 661 | Q96JA1 | |
| CILKDGIYSSAVVDN | 116 | P46934 | |
| GTEVKEDVVTACYAL | 326 | Q9UBB6 | |
| SSSGVCVLYECKDQT | 351 | Q99435 | |
| ISGLKSEVEANYHCS | 96 | A0A075B6J2 | |
| AAIDSCIAVTGKYQA | 556 | Q4ZG55 | |
| DVTGAQAYASTAKCL | 91 | Q01629 | |
| LAYAAAGELEKSSCD | 851 | Q9HBX8 | |
| SYVAAVCGKGEQVNS | 116 | Q9UBC5 | |
| IYLEAKGTSVCQAAA | 206 | Q96N19 | |
| GEVRNSKASAYCLDQ | 466 | Q9HCQ5 | |
| SKAEEGTYECTAVSR | 486 | Q8NDA2 | |
| RAQSSDAGVYTCKAS | 1591 | Q8NDA2 | |
| YTCAATNLAGESKRE | 1871 | Q8NDA2 | |
| AENAGRYSCKASNEV | 2821 | Q8NDA2 | |
| YTCVAENTQAEARKD | 3201 | Q8NDA2 | |
| LGYAKDVDQGSLCTS | 166 | O15111 | |
| SDKSASLNNVYLGCV | 136 | P54707 | |
| YLTSCASNSVKFGVE | 611 | Q5H9U9 | |
| EEDCFSNASVKVSYQ | 776 | P38570 | |
| EDVFQKNSDCVGSYT | 161 | O95382 | |
| VDVDKDSSLVTLCYG | 1781 | Q96RV3 | |
| VAYNSSGSCEIEKIV | 71 | Q6JVE9 | |
| GCVSDDSVKQYTSRD | 456 | Q8WWZ8 | |
| AYATADCDLGAVLKV | 301 | O00330 | |
| TDTVGLCGSYNNKAE | 946 | Q7Z5P9 | |
| SYSCKDTGFAAVVQD | 8251 | Q7Z5P9 | |
| VLSKSSGCAYQDVGV | 151 | P05164 | |
| SGEYDKAVDCFTAAL | 501 | P50542 | |
| CKDCYQIISGFTDSE | 611 | Q96M96 | |
| KVASGECNEDTEVYN | 131 | Q9H706 | |
| CGKAQNSTELAAEEY | 501 | P48506 | |
| EAAKCVSGSTAISTY | 6 | Q8NG66 | |
| AAGLYACTNNESTLK | 961 | Q14678 | |
| TLAHAGKYECEASNA | 336 | Q50LG9 | |
| AASYSETVTCEDAQK | 16 | P11226 | |
| ETSVALEKYQEACEN | 576 | P18074 | |
| STDTIYLLEGVCKND | 361 | P50748 | |
| SYCNVGDIEGASKIL | 206 | P42704 | |
| CFLTSDLNVKVGDYG | 271 | Q8IWU2 | |
| DAYKSQLSCVVVDDI | 591 | P46459 | |
| VLDASNQISVYKCGD | 441 | O95163 | |
| YSSLQDAVKGDCQSA | 321 | O76027 | |
| FNTVSKLDTGEYSCE | 201 | P57087 | |
| KLDTGEYSCEARNSV | 206 | P57087 | |
| TAKDCAGVILYSAEC | 356 | P26440 | |
| KCSILSNERGSQAYE | 1661 | Q2PPJ7 | |
| VSFCDKVGDQSLAYI | 286 | Q8N1E6 | |
| QVAASQKSVACDVGY | 866 | P17301 | |
| SILTGDKSISYNACA | 81 | A6NM76 | |
| EIDCSVDVQAFTGYK | 286 | Q6P9F7 | |
| ADDEYLVTSIAKACA | 246 | Q9NYA4 | |
| YTCIAKNEAGVDEDI | 411 | Q8N475 | |
| ETQDLDAGDYTCVAI | 761 | Q96RW7 | |
| YTCVAVNAAGEKQRD | 2081 | Q96RW7 | |
| ISIAEKSDAALYSCV | 2256 | Q96RW7 | |
| KSDAALYSCVASNVA | 2261 | Q96RW7 | |
| GEYTCIAINQAGESK | 3031 | Q96RW7 | |
| AETEDSGKYTCIASN | 3496 | Q96RW7 | |
| SGKYTCIASNEAGEV | 3501 | Q96RW7 | |
| DTANYTCVASNIAGK | 3686 | Q96RW7 | |
| ERVSKEDSGTYVCTA | 4316 | Q96RW7 | |
| GDKTISYNDCAAQLF | 86 | A6NCV1 | |
| SEETDQGKYECVATN | 206 | Q13332 | |
| VASVCNAYEKGVQSA | 51 | O60240 | |
| EAEVYAKQEANGKCS | 36 | A8MWK0 | |
| KDAGEYTCEVEASKS | 2891 | Q5VST9 | |
| ALEKADSDTYTCDIG | 2976 | Q5VST9 | |
| YTVSAKNEAGIVSCT | 1306 | Q8WX93 | |
| TYDDIENKVVADLGC | 46 | Q9NRN9 | |
| SGYNELKSCSFDNID | 76 | Q4G163 | |
| DTLKVTYDSFCSNGV | 376 | P05107 | |
| SDSEGVNCLAYDEAI | 16 | Q96FW1 | |
| VADGEVKHCVIYSTA | 396 | Q92569 | |
| SSEDTVNKATYCSVG | 186 | P38398 | |
| VNKATYCSVGDQELL | 191 | P38398 | |
| DSEYTCTIQRDAKGQ | 26 | Q7Z6J6 | |
| ESYRKIADSIGCSTN | 191 | Q9UHY7 | |
| VCSKEISALTDFSGY | 41 | P58658 | |
| TKTTLACLNGDYEVE | 441 | Q08828 | |
| EAFSESACIVEYGKA | 481 | Q05DH4 | |
| SISRASDTEAGKYQC | 631 | O75054 | |
| YEKAGSSETEIEVIC | 391 | Q01344 | |
| AAAKDSVEGICSKIY | 351 | Q9H4Z3 | |
| GNLSEKYVFITGCDS | 21 | Q8NEX9 | |
| YENVCKISGSSTDFQ | 81 | Q5T9S5 | |
| CKGGIRYSTDVSVDE | 146 | P00367 | |
| VIDLGSKRQYADCSE | 71 | Q08830 | |
| KSHGLVEVASYCEES | 131 | O75293 | |
| GFAYSSQEKACRDVD | 226 | Q14393 | |
| TVGAESYCKESDAQT | 511 | Q6PGQ7 | |
| ALVSVGEICQDYDSD | 416 | Q9UBL6 | |
| RDACLTGSKIQVDYD | 81 | Q12841 | |
| GTCFLQDGTKTVEYA | 156 | P06756 | |
| NQLKETTEAACRYGA | 166 | Q9Y2Q3 | |
| YTCEIDALKGTNDSL | 331 | P17661 | |
| SFGVVYQAKLCDSGE | 66 | P49841 | |
| TVEYACSAVKNLVDS | 66 | Q96FH0 | |
| CKAGFSEDDYTALIS | 31 | P55283 | |
| VYCVDVNEEKTESGN | 151 | Q5VT06 | |
| QEGACVYAVSDLRKS | 566 | P36269 | |
| DQCRDSITSYLKGEA | 4231 | Q12955 | |
| LGDSVDYVQVCDSDT | 226 | Q92839 | |
| EKYCTFNDDIQGTAA | 271 | P23368 | |
| TTKEQLGEFYEALDC | 151 | P02763 | |
| FKALGDSVDYIQVCD | 201 | O00219 | |
| EVNKGTNCVTSYLAD | 106 | O00519 | |
| STNVTDKDGELYCKV | 156 | P50461 | |
| GSFVSDLSSYCNKEV | 31 | Q969P5 | |
| GYQVRFDDCSSKETA | 131 | Q8IX18 | |
| CIAENKHGLVYSSAE | 386 | Q9P232 | |
| CKGGIRYSTDVSVDE | 146 | P49448 | |
| NTLLESDYCTAKGSE | 356 | Q8NC60 | |
| SDYCTAKGSEAIDRA | 361 | Q8NC60 | |
| AQDCSKGIYALVAQD | 321 | Q8N4N8 | |
| GKILSYNVSCSSDEE | 566 | P42702 | |
| AYSVGSKIEQECTEC | 451 | Q3ZCN5 | |
| VTVSVNECDKYLESS | 631 | Q5VU65 | |
| VYTDCSNKLAEGVLD | 1056 | Q5THK1 | |
| SSEESDQGKYECVAT | 196 | P10586 | |
| DQGKYECVATNSAGT | 201 | P10586 | |
| KGSVAEAEDCYNTAL | 306 | O15294 | |
| INSALYVEDKAISDC | 471 | A6NNC1 | |
| QSEESDQGKYECVAT | 196 | P23468 | |
| DQGKYECVATNSAGT | 201 | P23468 | |
| AKQIGAATYIECSAL | 166 | P61587 | |
| ISSVCLELYESDGKN | 436 | Q0VDF9 | |
| DVTGAQAYASTAKCL | 71 | P13164 | |
| DYLESKTCSLSGEQQ | 321 | P11717 | |
| SYSGELQLSVDCANK | 46 | P08247 | |
| CNKISADGYEVENLI | 16 | O94941 | |
| GCSSVDEESYKTLKQ | 381 | Q7L4I2 | |
| ETTKGAYCLSVSDFD | 181 | P12931 | |
| ASVQSDLKLCYEEAA | 661 | Q68CJ6 | |
| IESDYQSVSDLCKDQ | 161 | A8MYB1 | |
| VIDALYSDNISKENC | 126 | Q8IUX1 | |
| DVYQTEVTCHSLDGK | 136 | Q8WV15 | |
| YACSVRNSATGKEIS | 391 | Q00889 | |
| ESIQEYKGACQAASS | 116 | Q96GI7 | |
| KVGDLNRDYETCAVS | 166 | Q5QGS0 | |
| TYNAKATDAQLCLES | 446 | Q8NFP9 | |
| AVACFGVEELSKAYE | 1101 | Q99707 | |
| DLAKVGYLDSNTNSC | 916 | Q9C0A6 | |
| EGKIVVYTACNNGSS | 636 | O75592 | |
| GSVCSDADCQEYAKI | 4371 | O75592 | |
| SVLKGCTQAETQDGY | 3796 | P08F94 | |
| ENADGQTETCTTYSK | 336 | Q9BSU1 | |
| YVSLGSSEVENCKVG | 186 | Q8N9S9 | |
| TLGVTYLDENVKSSC | 246 | Q96BD0 | |
| SLTICEKASGYLQDS | 941 | P36956 | |
| NDGKECTLFETSYEL | 326 | A8MXE2 | |
| DCGEVTNYIEEKSST | 2121 | Q13023 | |
| TTATALKEEDGQVYC | 381 | Q9HAY6 | |
| AASCYDVQVIDDKGN | 386 | Q68CK6 | |
| DYIANCTVKVDQLGS | 621 | Q14865 | |
| GCSKTYQGLESLEEV | 161 | Q9UHD1 | |
| IQGYDNSESSVRKAC | 1226 | O75122 | |
| ANIDDAGIYKCVVTG | 86 | P13591 | |
| AKELGCSYTDVAAQD | 2001 | Q96JI7 | |
| SVARYASACKNADVE | 956 | O75443 | |
| GNVDFECDTKLYTSA | 416 | Q5QJE6 | |
| SCKENSYIVEDICSG | 221 | Q7Z2D5 | |
| TCEGLYDLSNKAASS | 426 | Q32MQ0 | |
| ACGLKTESYVQAASD | 51 | Q8IWX7 | |
| EDVKTCARDSGYDSL | 66 | Q8WYP3 | |
| GKAAELVTQNCEAYE | 306 | Q96I15 | |
| ESVLLYCHSSEGNKD | 396 | Q9Y4E5 | |
| TYNEDVLSKDAGECA | 186 | Q8NHG8 | |
| SECGKGFYESTALIQ | 311 | Q14592 | |
| DECGKTFAQTTYLID | 541 | O14709 | |
| LESKADGIEVSYNAC | 621 | Q7Z7L7 | |
| DSYSEKTCQQLGFES | 256 | Q9BYE2 | |
| EDSSNCDIVKATQYG | 46 | Q8IUH4 | |
| QESSYVCDECGKALT | 381 | P17023 | |
| AASAECQNYAKEVAG | 1211 | Q9P2E9 | |
| AHTSAGKTVCAEYAI | 161 | P42285 | |
| CEKNSVLEVIAYSSS | 391 | Q8NER1 | |
| LSCDISVDDKYIVTG | 746 | Q04727 | |
| EKDCTQAILLDGSYS | 336 | Q9H6T3 | |
| GLYTTAKADAEAECN | 61 | Q96ES7 | |
| IDYNVEQSCIKTEDG | 271 | O14662 | |
| EAACEKYTSGFDELQ | 366 | O43278 | |
| ECVYFVESSKLSDAG | 71 | O94759 | |
| YNGCSEANVTKEAFV | 91 | Q9UKY0 | |
| VSAEDEGTYTCVAEN | 316 | Q96MS0 | |
| ENLTVSECKSLHGEY | 696 | Q6U841 | |
| KGSVQVSDSAVYFCA | 96 | A0A087WT02 | |
| DKDTDSAITNCALSY | 2126 | P24821 | |
| ATDALCSVLYGKVSQ | 301 | Q86WB7 | |
| DSVTESTNGFYDCKE | 706 | Q9HBJ7 | |
| LEETDSGEYKCSATN | 481 | Q9BZZ2 | |
| KSLSEECQEVVDTYG | 351 | P07602 | |
| VGIDYARASKQVCND | 356 | P49746 | |
| VCSEDGKVQVFGLYS | 101 | P49754 | |
| DYFSCGKLDLSVTEA | 536 | P22102 | |
| NSEDIEACVSGQTKY | 126 | Q9Y5X0 | |
| EACVSGQTKYSVEEA | 131 | Q9Y5X0 | |
| SLYALGTQDSTDICK | 251 | Q9UNH7 | |
| SCDISADDKYIVTGS | 746 | Q04726 | |
| AEALGCEYEELNTAT | 856 | Q8IUG5 | |
| ENAKTYIASQGCLEA | 316 | P29350 | |
| DLNEYGTSCDKTTAV | 271 | Q5TYW1 | |
| GTSCDKTTAVEYNKV | 276 | Q5TYW1 | |
| VTGTDSQYCRKEVEA | 951 | O43379 | |
| VCEAYVKGSEFSANL | 161 | Q3KQV3 | |
| AVLGGSDSEKCSYSQ | 36 | Q8N806 | |
| ASAACEEIAYQVAGV | 1626 | Q9UL36 | |
| NVKSDIYSVGITACE | 246 | Q9C0K7 | |
| AVAEEESKGSATYCT | 56 | Q969S3 | |
| EVKGVTYCGESSASS | 601 | Q9NV66 | |
| TAYGQACDKTLSVAI | 276 | Q13769 | |
| AGVVEALYEAASQCE | 2016 | O15050 | |
| QGCEAVYSSVSGLKA | 411 | Q96ME7 | |
| YCISDTAVQEGLKCE | 1496 | Q68DK2 | |
| VKAGQSQDLALCDSY | 1991 | Q68DK2 | |
| LVKACGSSEASAYLD | 381 | Q8TD43 | |
| SYNDDVLTKDAGECV | 171 | Q8ND25 | |
| QEGDSAAALSLYCKA | 296 | Q6PHR2 | |
| SVQEGDSAVIKCTYS | 31 | A0A0B4J241 | |
| GEDAVINCSSSKALY | 36 | A0A087WSZ9 | |
| LCGYAVQDISKEDTV | 101 | Q8N402 | |
| VTDKDAGDYLCVARN | 2211 | Q9NR99 | |
| NLDYSDNGTFTCDVK | 116 | P25189 | |
| NKCTLADDAAYEVAV | 316 | Q14324 |